| 1 |
Duminuco A, Romano A, Leotta D, La Spina E, Cambria D, Bulla A, Del Fabro V, Tibullo D, Giallongo C, Palumbo GA, Conticello C, Di Raimondo F. Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab. Front Oncol 2023;13. [DOI: 10.3389/fonc.2023.1157610] [Reference Citation Analysis]
|
| 2 |
Mcdonnell T, Wu HHL, Kalra PA, Chinnadurai R. COVID-19 in Elderly Patients Receiving Haemodialysis: A Current Review. Biomedicines 2023;11:926. [DOI: 10.3390/biomedicines11030926] [Reference Citation Analysis]
|
| 3 |
Ioannou P, Katsigiannis A, Papakitsou I, Kopidakis I, Makraki E, Milonas D, Filippatos TD, Sourvinos G, Papadogiannaki M, Lydaki E, Chamilos G, Kofteridis DP. Convalescent Plasma Treatment of Patients Previously Treated with B-Cell-Depleting Monoclonal Antibodies Suffering COVID-19 Is Associated with Reduced Re-Admission Rates. Viruses 2023;15:756. [DOI: 10.3390/v15030756] [Reference Citation Analysis]
|
| 4 |
Oliva A, Cogliati Dezza F, Petrucci F, Romani FE, Morviducci M, Mirabelli FM, Cancelli F, Valeriani E, Marcelli G, Pugliese F, Turriziani O, Ricci P, Venditti M, Palange P, Mastroianni CM. Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2.0 study. Clin Exp Med 2023;:1-11. [PMID: 36867292 DOI: 10.1007/s10238-023-01027-y] [Reference Citation Analysis]
|
| 5 |
Xiong N, Sun Q. How does SARS-CoV-2 infection impact on immunity, procession and treatment of pan cancers. J Med Virol 2023;95:e28487. [PMID: 36625395 DOI: 10.1002/jmv.28487] [Reference Citation Analysis]
|
| 6 |
Passamonti F, Nicastri E, Di Rocco A, Guarini A, Ibatici A, Luminari S, Mikulska M, Visco C. Management of patients with lymphoma and COVID-19: Narrative review and evidence-based practical recommendations. Hematol Oncol 2023;41:3-15. [PMID: 36251481 DOI: 10.1002/hon.3086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Raad II, Hachem R, Masayuki N, Datoguia T, Dagher H, Jiang Y, Subbiah V, Siddiqui B, Bayle A, Somer R, Fernández Cruz A, Gorak E, Bhinder A, Mori N, Hamerschlak N, Shelanski S, Dragovich T, Vong Kiat YE, Fakhreddine S, Pierre AH, Chemaly RF, Mulanovich V, Adachi J, Borjan J, Khawaja F, Granwehr B, John T, Yepez EY, Torres HA, Ammakkanavar NR, Yibirin M, Reyes-Gibby CC, Pande M, Ali N, Rojo RD, Ali SM, Deeba RE, Chaftari P, Matsuo T, Ishikawa K, Hasegawa R, Aguado-Noya R, García AG, Puchol CT, Lee DG, Slavin M, Teh B, Arias CA, Kontoyiannis DP, Malek AE, Chaftari AM; Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship. Elife 2023;12. [PMID: 36715684 DOI: 10.7554/eLife.81127] [Reference Citation Analysis]
|
| 8 |
Oliva A, Dezza FC, Petrucci F, Romani FE, Morviducci M, Mirabelli FM, Cancelli F, Valeriani E, Marcelli G, Pugliese F, Turriziani O, Ricci P, Venditti M, Palange P, Mastroianni CM. Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2.0 study.. [DOI: 10.21203/rs.3.rs-2492556/v1] [Reference Citation Analysis]
|
| 9 |
Cordoba R, Lopez-Garcia A, Morillo D, Perez-Saenz MA, Askari E, Prieto RE, Castillo Bazan E, Llamas Sillero P, Herrero Gonzalez A, Short Apellaniz J, Del Olmo M, Arcos J. Feasibility of telemedicine in the management strategy of patients with lymphoma amid the COVID-19 pandemic in Spain, a prospective study. JMIR Form Res 2023. [PMID: 36645838 DOI: 10.2196/34128] [Reference Citation Analysis]
|
| 10 |
Llanos AAM, Ashrafi A, Ghosh N, Tsui J, Lin Y, Fong AJ, Ganesan S, Heckman CJ. Evaluation of Inequities in Cancer Treatment Delay or Discontinuation Following SARS-CoV-2 Infection. JAMA Netw Open 2023;6:e2251165. [PMID: 36637818 DOI: 10.1001/jamanetworkopen.2022.51165] [Reference Citation Analysis]
|
| 11 |
Konrat J, Rösler W, Roiss M, Meier-Abt F, Widmer CC, Balabanov S, Manz MG, Zenz T. BRAF inhibitor treatment of classical hairy cell leukemia allows successful vaccination against SARS-CoV-2. Ann Hematol 2023;102:403-6. [PMID: 36494600 DOI: 10.1007/s00277-022-05026-z] [Reference Citation Analysis]
|
| 12 |
Ljungman P, Tridello G, Piñana JL, Ciceri F, Sengeloev H, Kulagin A, Mielke S, Yegin ZA, Collin M, Einardottir S, Lepretre SD, Maertens J, Campos A, Metafuni E, Pichler H, Folber F, Solano C, Nicholson E, Yüksel MK, Carlson K, Aguado B, Besley C, Byrne J, Heras I, Dignan F, Kröger N, Robin C, Khan A, Lenhoff S, Grassi A, Dobsinska V, Miranda N, Jimenez MJ, Yonal-Hindilerden I, Wilson K, Averbuch D, Cesaro S, Xhaard A, Knelange N, Styczynski J, Mikulska M, de la Camara R. Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry. Front Immunol 2023;14:1125824. [PMID: 36960069 DOI: 10.3389/fimmu.2023.1125824] [Reference Citation Analysis]
|
| 13 |
Schmidt-hieber M, Teschner D, Desole M, Link H, Maschmeyer G, Schalk E. Therapie von Infektionen bei Tumorpatienten. Springer Reference Medizin 2023. [DOI: 10.1007/978-3-662-46764-0_155-2] [Reference Citation Analysis]
|
| 14 |
Laurenge A, Ursu R, Tabouret E, Harlay V, Ahle G, Choquet S, Soussain C, Moluçon-Chabrot C, Mathon B, Mokhtari K, Pourcher V, Nichelli L, Marot S, Touat M, Hoang-Xuan K, Houillier C. SARS-CoV-2 infection in patients with primary central nervous system lymphoma in the vaccination era. Leuk Lymphoma 2023;64:221-4. [PMID: 36318828 DOI: 10.1080/10428194.2022.2131420] [Reference Citation Analysis]
|
| 15 |
Aktaş Özakgül A, Durmayüksel E, Topçu YG, Gözden H. Non-Hodgkin Lenfoma ve COVID-19 Pnömonisi olan Hastanın Bireyselleştirilmiş Bakımı: Olgu Sunumu. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi 2022;11:1699-1714. [DOI: 10.37989/gumussagbil.961384] [Reference Citation Analysis]
|
| 16 |
Fajardoa CJ, Cálixb ES, Mojicac R, Duarted F. COVID-19 in patients with chronic myeloid leukaemia on tyrosine kinase inhibitor therapy: a Honduran observational study. Ecancermedicalscience 2022;16:1481. [PMID: 36819815 DOI: 10.3332/ecancer.2022.1481] [Reference Citation Analysis]
|
| 17 |
Refaat L, Abdellateif MS, Bayoumi A, Khafagy M, Kandeel EZ, Nooh HA. Detection of abnormal lymphocytes in the peripheral blood of COVID-19 cancer patients: diagnostic and prognostic possibility. Hematology 2022;27:745-56. [PMID: 35724413 DOI: 10.1080/16078454.2022.2089830] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Casetti IC, Borsani O, Rumi E. COVID-19 in Patients with Hematologic Diseases. Biomedicines 2022;10. [PMID: 36551825 DOI: 10.3390/biomedicines10123069] [Reference Citation Analysis]
|
| 19 |
Li C, Zhang Y, Xiao Y, Luo Y. Identifying the Effect of COVID-19 Infection in Multiple Myeloma and Diffuse Large B-Cell Lymphoma Patients Using Bioinformatics and System Biology. Computational and Mathematical Methods in Medicine 2022;2022:1-12. [DOI: 10.1155/2022/7017317] [Reference Citation Analysis]
|
| 20 |
Wu HHL, Athwal VS, Kalra PA, Chinnadurai R. COVID-19 and hepatorenal syndrome. World J Gastroenterol 2022; 28(39): 5666-5678 [DOI: 10.3748/wjg.v28.i39.5666] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Carrara E, Razzaboni E, Azzini AM, De Rui ME, Pinho Guedes MN, Gorska A, Giannella M, Bussini L, Bartoletti M, Arbizzani F, Palacios-Baena ZR, Caponcello G, Maldonado N, Rodríguez-Baño J, Visco C, Krampera M, Tacconelli E. Predictors of clinical evolution of SARS-CoV-2 infection in hematological patients: A systematic review and meta-analysis. Hematol Oncol 2023;41:16-25. [PMID: 36238977 DOI: 10.1002/hon.3084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Qatawneh MA, Altarawneh M, Alhazaimeh R, Jazazi M, Jarrah O, Shorman A, Alsadah L, Mustafa M. Manifestations of COVID-19 infection in children with malignancy: A single-center experience in Jordan. World J Virol 2022; 11(5): 321-330 [DOI: 10.5501/wjv.v11.i5.321] [Reference Citation Analysis]
|
| 23 |
Poghosyan H, Dinan MA, Tamamyan G, Nelson L, Jeon S. Racial and Ethnic Variation in COVID-19 Vaccination Uptake Among Medicare Beneficiaries with Cancer History. J Racial Ethn Health Disparities 2022;:1-9. [PMID: 36149576 DOI: 10.1007/s40615-022-01415-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 24 |
Bouleftour W, Bonjean P, Grangeon K, Magné N. COVID-19 vaccine-related adverse events in solid cancer patients treated with immunotherapy. Cancer Invest 2022;:1-10. [PMID: 36062881 DOI: 10.1080/07357907.2022.2121966] [Reference Citation Analysis]
|
| 25 |
Cotorogea-Simion M, Pavel B, Isac S, Telecan T, Matache IM, Bobirca A, Bobirca FT, Rababoc R, Droc G. What Is Different in Acute Hematologic Malignancy-Associated ARDS? An Overview of the Literature. Medicina (Kaunas) 2022;58:1215. [PMID: 36143892 DOI: 10.3390/medicina58091215] [Reference Citation Analysis]
|
| 26 |
Wu M, Liu S, Yang Y, Lin J, Liu J. Clinical characteristics and outcomes of lung cancer patients with COVID-19: A systematic review and meta-analysis protocol. PLoS ONE 2022;17:e0273691. [DOI: 10.1371/journal.pone.0273691] [Reference Citation Analysis]
|
| 27 |
Raad I, Hachem R, Masayuki N, Datoguia T, Dagher H, Jiang Y, Subbiah V, Siddiqui B, Bayle A, Somer R, Cruz AF, Gorak E, Bhinder A, Mori N, Hamerschlak N, Shelanski S, Dragivich T, Kiat YEV, Fakhreddine S, Hanna PA, Chemaly RF, Mulanovich V, Adachi J, Borjan J, Khawaja F, Granwehr B, John T, Guevara EY, Torres H, Ammakkanavar NR, Yibirin M, Reyes-Gibby CC, Pande M, Ali N, Rojo RD, Ali SM, Deeba RE, Chaftari P, Matsuo T, Ishikawa K, Hasegawa R, Aguado-Noya R, García-García Á, Puchol CT, Lee DG, Slavin M, Teh B, Arias CA, Kontoyiannis DP, Malek AE, Chaftari AM; Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship. medRxiv 2022:2022. [PMID: 36097568 DOI: 10.1101/2022.08.25.22279181] [Reference Citation Analysis]
|
| 28 |
Abu Shanap M, Sughayer M, Alsmadi O, Elzayat I, Al-nuirat A, Tbakhi A, Sultan I. Factors that predict severity of infection and seroconversion in immunocompromised children and adolescents with COVID-19 infection. Front Immunol 2022;13:919762. [DOI: 10.3389/fimmu.2022.919762] [Reference Citation Analysis]
|
| 29 |
Laracy JC, Kamboj M, Vardhana SA. Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside. Curr Opin Infect Dis 2022;35:271-9. [PMID: 35849516 DOI: 10.1097/QCO.0000000000000841] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 30 |
Al-mansour M. Treatment Landscape of Relapsed/Refractory Mantle Cell Lymphoma: An Updated Review. Clinical Lymphoma Myeloma and Leukemia 2022. [DOI: 10.1016/j.clml.2022.07.017] [Reference Citation Analysis]
|
| 31 |
Tabatabai J, Schnitzler P, Prifert C, Schiller M, Weissbrich B, von Lilienfeld-toal M, Teschner D, Jordan K, Müller-tidow C, Egerer G, Giesen N. Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral shedding. PLoS ONE 2022;17:e0271756. [DOI: 10.1371/journal.pone.0271756] [Reference Citation Analysis]
|
| 32 |
Llanos AAM, Fong AJ, Ghosh N, Devine KA, O'Malley D, Paddock LE, Bandera EV, Hudson SV, Evens AM, Manne SL. COVID-19 perceptions, impacts, and experiences: a cross-sectional analysis among New Jersey cancer survivors. J Cancer Surviv 2022. [PMID: 35904727 DOI: 10.1007/s11764-022-01236-6] [Reference Citation Analysis]
|
| 33 |
Khaja M, Hayagreev V, Haider A, Ronderos D, Siddiqa A, Moirangthem V. Co-occurrence of CML Blast Crisis and Severe COVID 19 Infection: A Case Report. Cureus 2022. [DOI: 10.7759/cureus.26865] [Reference Citation Analysis]
|
| 34 |
Ramlall V, May B, Tatonetti NP. Using machine learning probabilities to identify effects of COVID-19.. [DOI: 10.1101/2022.07.02.22277179] [Reference Citation Analysis]
|
| 35 |
A O, A C, L V, F C, C B, F CD, G M, F G, S DB, P R, O T, Cm M, M V. Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non-haematological ones: results from a case-control study. Infection 2022. [PMID: 35781785 DOI: 10.1007/s15010-022-01869-w] [Reference Citation Analysis]
|
| 36 |
Choi S, La I, Han X, Men X, Lee S, Oh G, Kwon H, Kim Y, Seong G, Kim S, Lee O. Immunomodulatory Effect of Polysaccharide from Fermented Morinda citrifolia L. (Noni) on RAW 264.7 Macrophage and Balb/c Mice. Foods 2022;11:1925. [DOI: 10.3390/foods11131925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 37 |
D'Abramo A, Vita S, Maffongelli G, Beccacece A, Agrati C, Cimini E, Colavita F, Giancola ML, Cavasio A, Nicastri E; Spallanzani COVID-19 Case Investigation Team. Clinical Management of Patients With B-Cell Depletion Agents to Treat or Prevent Prolonged and Severe SARS-COV-2 Infection: Defining a Treatment Pathway. Front Immunol 2022;13:911339. [PMID: 35711444 DOI: 10.3389/fimmu.2022.911339] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 38 |
Gueuning C, Ameye L, Loizidou A, Grigoriu B, Meert AP. PARIS score for evaluation of probability of SARS-CoV-2 infection in cancer patients. Support Care Cancer 2022. [PMID: 35678883 DOI: 10.1007/s00520-022-07199-9] [Reference Citation Analysis]
|
| 39 |
Goldman JD, Gonzalez MA, Rüthrich MM, Sharon E, von Lilienfeld-Toal M. COVID-19 and Cancer: Special Considerations for Patients Receiving Immunotherapy and Immunosuppressive Cancer Therapies. Am Soc Clin Oncol Educ Book 2022;42:1-13. [PMID: 35658503 DOI: 10.1200/EDBK_359656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Azem A, Ajmal Z, Raval M. Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant: SARS-CoV-2 Vaccine as a Potential Trigger. Cureus. [DOI: 10.7759/cureus.25738] [Reference Citation Analysis]
|
| 41 |
Freeman V, Hughes S, Carle C, Campbell D, Egger S, Hui H, Yap S, Deandrea S, Caruana M, Onyeka TC, IJzerman MJ, Ginsburg O, Bray F, Sullivan R, Aggarwal A, Peacock SJ, Chan KKW, Hanna TP, Soerjomataram I, O'Connell DL, Steinberg J, Canfell K. Are patients with cancer at higher risk of COVID-19-related death? A systematic review and critical appraisal of the early evidence. J Cancer Policy 2022;33:100340. [PMID: 35680113 DOI: 10.1016/j.jcpo.2022.100340] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 42 |
Totschnig D, Doberer D, Haberl R, Wenisch C, Valipour A. Treatment of persistent COVID-19 in two B-cell-depleted patients with the monoclonal antibody Sotrovimab. IDCases 2022. [DOI: 10.1016/j.idcr.2022.e01528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 43 |
Zhou J, Lakhani I, Chou O, Leung KSK, Lee TTL, Wong MV, Li Z, Wai AKC, Chang C, Wong ICK, Zhang Q, Tse G, Cheung BMY. Clinical characteristics, risk factors and outcomes of cancer patients with COVID-19: A population-based study. Cancer Med 2023;12:287-96. [PMID: 35642123 DOI: 10.1002/cam4.4888] [Reference Citation Analysis]
|
| 44 |
Tsilingiris D, Nasiri-ansari N, Spyrou N, Magkos F, Dalamaga M. Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges. Cancers 2022;14:2494. [DOI: 10.3390/cancers14102494] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 45 |
Rodríguez-Mora S, Corona M, Torres M, Casado-Fernández G, García-Pérez J, Ramos-Martín F, Vigón L, Manzanares M, Mateos E, Martín-Moro F, Zurdo-Castronuño A, Murciano-Antón MA, Alcamí J, Pérez-Olmeda M, López-Jiménez J, García-Gutiérrez V, Coiras M, On Behalf Of The Multidisciplinary Group Of Study Of Covid-Mgs-Covid. Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19. J Clin Med 2022;11:2803. [PMID: 35628927 DOI: 10.3390/jcm11102803] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 46 |
Sagnelli C, Sica A, Creta M, Borsetti A, Ciccozzi M, Sagnelli E. Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19. Pathogens 2022;11:567. [DOI: 10.3390/pathogens11050567] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 47 |
Khoury E, Nevitt S, Madsen WR, Turtle L, Davies G, Palmieri C. Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer: A Systematic Review and Meta-analysis. JAMA Netw Open 2022;5:e2210880. [PMID: 35532936 DOI: 10.1001/jamanetworkopen.2022.10880] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 23.0] [Reference Citation Analysis]
|
| 48 |
Baptista JPR, Wozniaki N, Cassi Junior HV, Neves GD, Boettcher IS, Dall'Oglio AC, Tavares FS, Gastal GR, Schwingel FL, de Lacerda MP. Severity and One-Year Cumulative Incidence of COVID-19 Among Inpatients with Haematologic Malignancies. J Hosp Infect 2022:S0195-6701(22)00125-6. [PMID: 35513183 DOI: 10.1016/j.jhin.2022.04.011] [Reference Citation Analysis]
|
| 49 |
Itoh K, Tsutani H, Iwasaki H. Multifaceted efficacy of caspofungin against fungal infections in COVID-19 patients. Medical Hypotheses 2022. [DOI: 10.1016/j.mehy.2022.110876] [Reference Citation Analysis]
|
| 50 |
Dopfer-Jablonka A, Steffens S, Müller F, Mikuteit M, Niewolik J, Cossmann A, Stankov MV, Behrens GMN, Hummers E, Heesen G, Schröder D, Roder S, Klawonn F, Vahldiek K, Hasenkamp J, Kallusky J, Falk CS, Overbeck TR, Heinemann S. SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study. BMC Infect Dis 2022;22:403. [PMID: 35468758 DOI: 10.1186/s12879-022-07347-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 51 |
Levy G, Guglielmelli P, Langmuir P, Constantinescu S. JAK inhibitors and COVID-19. J Immunother Cancer 2022;10:e002838. [PMID: 35459733 DOI: 10.1136/jitc-2021-002838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 52 |
Zaki A, Soomar SM, Khan DH, Shaharyar Sheikh H, Iftikhar R, Mir A, Aziz Z, Bano K, Naseer H, Chaudhry QU, Bokhari SWI, Shabbir-moosajee M. “Outcomes of COVID-19 infection in patients with hematological malignancies- A multicenter analysis from Pakistan”. PLoS ONE 2022;17:e0267139. [DOI: 10.1371/journal.pone.0267139] [Reference Citation Analysis]
|
| 53 |
Deveci B, Döşemeci L, Aslan A, Asal G, Üstün B, Yildirmer Akar M, Toptas T, Yavuz Taşlipinar M, Saba R. Determinants of clinical course and mortality in COVID-19 patients with hematological disorders: real life data from a single center. The European Research Journal 2022. [DOI: 10.18621/eurj.1000067] [Reference Citation Analysis]
|
| 54 |
Eidininkienė M, Cesarskaja J, Talačkaitė S, Traškaitė-juškevičienė V, Macas A. Mini Review: Co-Existing Diseases and COVID-19—A One Way Ticket? IJERPH 2022;19:4738. [DOI: 10.3390/ijerph19084738] [Reference Citation Analysis]
|
| 55 |
Sychevskaya KA, Kravchenko SK. Monoclonal anti-CD20 antibodies in lymphomas therapy during the COVID-19 pandemic: pro and contra. Onkogematologiâ 2022;17:95-106. [DOI: 10.17650/1818-8346-2022-17-2-95-106] [Reference Citation Analysis]
|
| 56 |
Naimi A, Yashmi I, Jebeleh R, Imani Mofrad M, Azimian Abhar S, Jannesar Y, Heidary M, Pakzad R. Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: A systematic review and meta-analysis. J Clin Lab Anal 2022;:e24387. [PMID: 35385130 DOI: 10.1002/jcla.24387] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 57 |
Aygüneş U, Karagün B, Şaşmaz Hİ, Akbaş T, Antmen AB. Clinical and radiological features of COVID-19 infection in pediatric hematology-oncology and transplant patients. Cukurova Medical Journal 2022;47:377-88. [DOI: 10.17826/cumj.1036774] [Reference Citation Analysis]
|
| 58 |
Bouchlarhem A, Es-Saad O, Haddar L, Lamzouri O, Elaidouni G, Mimouni H, Bkiyar H, Housni B. Special case of a patient in the blast phase of chronic myeloid leukemia successfully treated with tocilizumab during critical SARS-CoV-2 infection. J Int Med Res 2022;50:3000605221082875. [PMID: 35301903 DOI: 10.1177/03000605221082875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 59 |
Romano A, Cerchione C, Conticello C, Filetti S, Bulla A, Chiarenza A, Del Fabro V, Leotta S, Markovic U, Motta G, Parisi M, Stagno F, Palumbo GA, Di Raimondo F. Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection. Cancers (Basel) 2022;14:1173. [PMID: 35267478 DOI: 10.3390/cancers14051173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 60 |
Cao Y, Wu D, Zeng K, Chen L, Yu J, He W, Chen L, Ren W, Gao F, Chen W, Wang H, Gale RP, Chen Z, Li Q. COVID-19 in China and the US: Differences in Hospital Admission Co-Variates and Outcomes. Vaccines 2022;10:326. [DOI: 10.3390/vaccines10020326] [Reference Citation Analysis]
|
| 61 |
Han S, Zhuang Q, Chiang J, Tan SH, Chua GWY, Xie C, Chua MLK, Soon YY, Yang VS. Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis. BMJ Open 2022;12:e044661. [PMID: 35131810 DOI: 10.1136/bmjopen-2020-044661] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 62 |
Tığlıoğlu P, Albayrak M, Tığlıoğlu M, Öztürk HBA, Aras MR, Sağlam B, Maral S. The outcome of COVID-19 in patients with hematological malignancy. memo 2022;15:83-89. [DOI: 10.1007/s12254-021-00775-5] [Reference Citation Analysis]
|
| 63 |
Mohseni Afshar Z, Hosseinzadeh R, Barary M, Ebrahimpour S, Alijanpour A, Sayad B, Hosseinzadeh D, Miri SR, Sio TT, Sullman MJM, Carson-Chahhoud K, Babazadeh A. Challenges posed by COVID-19 in cancer patients: A narrative review. Cancer Med 2022;11:1119-35. [PMID: 34951152 DOI: 10.1002/cam4.4519] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 64 |
Arellano-llamas AA, Vela-ojeda J, Hernandez-caballero A. Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic. Curr Oncol Rep. [DOI: 10.1007/s11912-022-01198-z] [Reference Citation Analysis]
|
| 65 |
Elamin MM. A Review on CRP Analysis and Obesity Influence in the Disparity of COVID-19 Pandemic. Pharmacophore 2022;13:48-55. [DOI: 10.51847/b3k4cepnia] [Reference Citation Analysis]
|
| 66 |
Aggarwal M, Amjad MS, Khandelwal A, Kumar P, Dhawan R, Dass J, Ganesh KV, Khanna P, Singh AK, Soni KD, Agarwal R, Bairwa M, Selvi A, Tyagi S, Seth T, Mahapatra M, Wig N, Trikha A. COVID-19 infection in patients with haematological disease - A tertiary centre experience from north India. Indian J Med Res 2022;155:570-4. [PMID: 35975348 DOI: 10.4103/ijmr.ijmr_1180_21] [Reference Citation Analysis]
|
| 67 |
Costa BA, da Luz KV, Campos SEV, Lopes GS, Leitão JPDV, Duarte FB. Can SARS-CoV-2 induce hematologic malignancies in predisposed individuals? A case series and review of the literature. Hematology, Transfusion and Cell Therapy 2022;44:26-31. [DOI: 10.1016/j.htct.2021.11.015] [Reference Citation Analysis]
|
| 68 |
Schmidt-hieber M, Teschner D, Desole M, Link H, Maschmeyer G, Schalk E. Therapie von Infektionen bei Tumorpatienten. Springer Reference Medizin 2022. [DOI: 10.1007/978-3-662-46764-0_155-1] [Reference Citation Analysis]
|
| 69 |
Khoury E, Nevitt S, Madsen WR, Turtle L, Davies G, Palmieri C. A comprehensive systematic review and meta-analysis of the global data involving 61,532 cancer patients with SARS-CoV-2 infection.. [DOI: 10.1101/2021.12.18.21267261] [Reference Citation Analysis]
|
| 70 |
Passamonti F, Corrao G, Castellani G, Mora B, Maggioni G, Gale RP, Della Porta MG. The future of research in hematology: Integration of conventional studies with real-world data and artificial intelligence. Blood Rev 2021;:100914. [PMID: 34996639 DOI: 10.1016/j.blre.2021.100914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 71 |
Jafari M, Dastgheib SA, Ferdosian F, Mirjalili H, Aarafi H, Noorishadkam M, Mazaheri M, Neamatzadeh H. Proportion of Hematological Cancer Patients with SARS-CoV-2 Infection during the COVID-19 Pandemic: a Systematic Review and Meta-Analysis. Hematol Transfus Cell Ther 2021. [PMID: 34931178 DOI: 10.1016/j.htct.2021.09.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 72 |
Bonuomo V, Ferrarini I, Dell'Eva M, Sbisà E, Krampera M, Visco C. COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review. World J Virol 2021; 10(6): 312-325 [PMID: 34909405 DOI: 10.5501/wjv.v10.i6.312] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 73 |
Jeyalan V, Storrar J, Wu HHL, Ponnusamy A, Sinha S, Kalra PA, Chinnadurai R. Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review. World J Transplant 2021; 11(11): 480-502 [PMID: 34868898 DOI: 10.5500/wjt.v11.i11.480] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 74 |
Papakonstantinou E, Dragoumani K, Efthimiadou A, Palaiogeorgou AM, Pierouli K, Mitsis T, Chrousos GP, Bacopoulou F, Vlachakis D. Haematological malignancies implications during the times of the COVID-19 pandemic. Oncol Lett 2021;22:856. [PMID: 34777590 DOI: 10.3892/ol.2021.13117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 75 |
Wang XA, Binder AF, Gergis U, Wilde L. COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective Study. Front Oncol 2021;11:740320. [PMID: 34778057 DOI: 10.3389/fonc.2021.740320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 76 |
Charwudzi A, Meng Y, Hu L, Ding C, Pu L, Li Q, Xu M, Zhai Z, Xiong S. Integrated bioinformatics analysis reveals dynamic candidate genes and signaling pathways involved in the progression and prognosis of diffuse large B-cell lymphoma. PeerJ 2021;9:e12394. [PMID: 34760386 DOI: 10.7717/peerj.12394] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 77 |
Stein D, Oviedo-orta E, Kampman WA, Mcginniss J, Betts G, Mcdermott M, Holly B, Lancaster JM, Braunstein N, Yancopoulos GD, Weinreich DM. Compassionate Use of REGEN-COV® in Patients with COVID-19 and Immunodeficiency-Associated Antibody Disorders.. [DOI: 10.1101/2021.11.05.21265911] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 78 |
Luxi N, Giovanazzi A, Capuano A, Crisafulli S, Cutroneo PM, Fantini MP, Ferrajolo C, Moretti U, Poluzzi E, Raschi E, Ravaldi C, Reno C, Tuccori M, Vannacci A, Zanoni G, Trifirò G; Ilmiovaccino COVID19 collaborating group. COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety. Drug Saf 2021;44:1247-69. [PMID: 34739716 DOI: 10.1007/s40264-021-01131-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 79 |
Kandeel EZ, Refaat L, Abdel-Fatah R, Samra M, Bayoumi A, Abdellateif MS, Abdel-Hady H, Ali M, Khafagy M. Could COVID-19 induce remission of acute leukemia? Hematology 2021;26:870-3. [PMID: 34719343 DOI: 10.1080/16078454.2021.1992117] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 80 |
Chatzikonstantinou T, Kapetanakis A, Scarfò L, Karakatsoulis G, Allsup D, Cabrero AA, Andres M, Antic D, Baile M, Baliakas P, Bron D, Capasso A, Chatzileontiadou S, Cordoba R, Correa JG, Cuéllar-García C, De Paoli L, De Paolis MR, Del Poeta G, Demosthenous C, Dimou M, Donaldson D, Doubek M, Efstathopoulou M, Eichhorst B, El-Ashwah S, Enrico A, Espinet B, Farina L, Ferrari A, Foglietta M, Frederiksen H, Fürstenau M, García-Marco JA, García-Serra R, Gentile M, Gimeno E, Glenthøj A, Gomes da Silva M, Gutwein O, Hakobyan YK, Herishanu Y, Hernández-Rivas JÁ, Herold T, Innocenti I, Itchaki G, Jaksic O, Janssens A, Kalashnikova ОB, Kalicińska E, Karlsson LK, Kater AP, Kersting S, Labrador J, Lad D, Laurenti L, Levin MD, Lista E, Lopez-Garcia A, Malerba L, Marasca R, Marchetti M, Marquet J, Mattsson M, Mauro FR, Milosevic I, Mirás F, Morawska M, Motta M, Munir T, Murru R, Niemann CU, Rodrigues RN, Olivieri J, Orsucci L, Papaioannou M, Pavlovsky MA, Piskunova I, Popov VM, Quaglia FM, Quaresmini G, Qvist K, Reda G, Rigolin GM, Ruchlemer R, Saghumyan G, Shrestha A, Šimkovič M, Špaček M, Sportoletti P, Stanca O, Stavroyianni N, Tadmor T, Te Raa D, Tonino SH, Trentin L, Van Der Spek E, van Gelder M, van Kampen R, Varettoni M, Visentin A, Vitale C, Wasik-Szczepanek E, Wróbel T, San Segundo LY, Yassin M, Coscia M, Rambaldi A, Montserrat E, Foà R, Cuneo A, Stamatopoulos K, Ghia P. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study. Leukemia 2021. [PMID: 34725454 DOI: 10.1038/s41375-021-01450-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 81 |
Ali H, Ngo D, Aribi A, Arslan S, Dadwal S, Marcucci G, Nakamura R, Forman SJ, Chen J, Al Malki MM. Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients. Transplant Cell Ther 2021;27:938.e1-6. [PMID: 34274492 DOI: 10.1016/j.jtct.2021.07.008] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 18.5] [Reference Citation Analysis]
|
| 82 |
Jafari A, Mahboubi-fooladi Z, Siavashpour Z, Rakhsha A, Mirbaha S, Fatemi A, Forouzanfar MM. Clinical and Imaging Characteristics of Cancer Patients with COVID-19: A Pilot Study. Int J Cancer Manag 2021;14. [DOI: 10.5812/ijcm.115735] [Reference Citation Analysis]
|
| 83 |
Mileham KF, Bruinooge SS, Aggarwal C, Patrick AL, Davis C, Mesenhowski DJ, Spira A, Clayton EJ, Waterhouse D, Moore S, Jazieh AR, Chen RC, Kaltenbaugh M, Williams JH, Gralow JR, Schilsky RL, Garrett-Mayer E. Changes Over Time in COVID-19 Severity and Mortality in Patients Undergoing Cancer Treatment in the United States: Initial Report From the ASCO Registry. JCO Oncol Pract 2021;:OP2100394. [PMID: 34694907 DOI: 10.1200/OP.21.00394] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 84 |
Kang KW, Lee BH, Jeon MJ, Yu ES, Kim DS, Lee SR, Sung HJ, Choi CW, Park Y, Kim BS. The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma. Korean J Intern Med 2021;36:1459-70. [PMID: 34666434 DOI: 10.3904/kjim.2021.186] [Reference Citation Analysis]
|
| 85 |
Kılıçaslan E, Erdoğan Özünal I, Elibol T, Öztürk E. Are Hematologic Patients Trojan Horse for COVID-19? Indian J Hematol Blood Transfus 2021;:1-7. [PMID: 34667375 DOI: 10.1007/s12288-021-01498-7] [Reference Citation Analysis]
|
| 86 |
Breccia M, Abruzzese E, Accurso V, Attolico I, Barulli S, Bergamaschi M, Binotto G, Bocchia M, Bonifacio M, Caocci G, Capodanno I, Castagnetti F, Cavazzini F, Crisà E, Crugnola M, Stella De Candia M, Elena C, Fava C, Galimberti S, Gozzini A, Gugliotta G, Intermesoli T, Iurlo A, La Barba G, Latagliata R, Leonetti Crescenzi S, Levato L, Loglisci G, Lucchesi A, Luciano L, Lunghi F, Luzi D, Malato A, Cristina Miggiano M, Pizzuti M, Pregno P, Rapezzi D, Rege-Cambrin G, Rosti G, Russo S, Sancetta R, Rita Scortechini A, Sorà F, Sportoletti P, Stagno F, Tafuri A, Tiribelli M, Foà R, Saglio G. COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report. Br J Haematol 2021. [PMID: 34636033 DOI: 10.1111/bjh.17890] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 87 |
Cordoba R, Lopez-garcia A, Morillo D, Perez-saenz M, Askari E, Prieto E, Castillo E, Llamas P, Pardo A, Herrero A, Short J, del Olmo M, Arcos J. Feasibility of telemedicine in the management strategy of patients with lymphoma amid the COVID-19 pandemic in Spain, a prospective study (Preprint).. [DOI: 10.2196/preprints.34128] [Reference Citation Analysis]
|
| 88 |
Strickland M, Quek L, Psaila B. The immune landscape in BCR-ABL negative myeloproliferative neoplasms: inflammation, infections and opportunities for immunotherapy. Br J Haematol 2021. [PMID: 34618358 DOI: 10.1111/bjh.17850] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 89 |
Ramasamy C, Mishra AK, John KJ, Lal A. Clinical considerations for critically ill COVID-19 cancer patients: A systematic review. World J Clin Cases 2021; 9(28): 8441-8452 [PMID: 34754852 DOI: 10.12998/wjcc.v9.i28.8441] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 90 |
Hu Y, Wang L, Cui Q, Su Yin ET, Wu H, Nagler A, Huang H. COVID-19 in Hematologic Malignancies: Big Challenges. Clin Hematol Int 2020;2:173-5. [PMID: 34595459 DOI: 10.2991/chi.k.200919.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 91 |
Söhn C, Bott A. Morbidität und Letalität einer COVID-19-Erkrankung bei Tumorpatienten. InFo Hämatol Onkol 2021;24:33-34. [DOI: 10.1007/s15004-021-8814-4] [Reference Citation Analysis]
|
| 92 |
Russell B, Moss CL, Shah V, Ko TK, Palmer K, Sylva R, George G, Monroy-Iglesias MJ, Patten P, Ceesay MM, Benjamin R, Potter V, Pagliuca A, Papa S, Irshad S, Ross P, Spicer J, Kordasti S, Crawley D, Wylie H, Cahill F, Haire A, Zaki K, Sita-Lumsden A, Josephs D, Enting D, Swampillai A, Sawyer E, D'Souza A, Gomberg S, Harrison C, Fields P, Wrench D, Rigg A, Sullivan R, Kulasekararaj A, Dolly S, Van Hemelrijck M; Guy’s Cancer Real World Evidence. Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London. Br J Cancer 2021;125:939-47. [PMID: 34400804 DOI: 10.1038/s41416-021-01500-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 93 |
Gupta A, Desai N, Sanjeev, Chauhan P, Nityanand S, Hashim Z, Gupta M. Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India. Ann Hematol 2021. [PMID: 34559278 DOI: 10.1007/s00277-021-04644-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 94 |
Buti S, Perrone F, Zielli T, Mazzaschi G, Casartelli C, Leonetti A, Milanese G, Silva M, Eufrasia Ledda R, Musolino A, Pucci F, Bersanelli M, Tiseo M. Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study. Clin Med Insights Oncol 2021;15:11795549211043427. [PMID: 34526833 DOI: 10.1177/11795549211043427] [Reference Citation Analysis]
|
| 95 |
Dang MKM, Bhatt I, Dulu AO, Zhang H, Kostelecky N, Pastores SM. Clinical Characteristics, Management, and Outcomes of Cancer Patients With Coronavirus Disease 2019 Admitted to the ICU. Crit Care Explor 2021;3:e0535. [PMID: 34514429 DOI: 10.1097/CCE.0000000000000535] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 96 |
Wang F, Si Y, Yu J, Ding B. Tailoring Nanonets‐Engineered Superflexible Nanofibrous Aerogels with Hierarchical Cage‐Like Architecture Enables Renewable Antimicrobial Air Filtration. Adv Funct Mater 2021;31:2107223. [DOI: 10.1002/adfm.202107223] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 97 |
Petzer V, Schwendinger S, Haschka D, Vogi V, Tymoszuk P, Burkert F, Sahanic S, Sonnweber T, Bellmann-Weiler R, Loeffler-Ragg J, Tancevski I, Zschocke J, Weiss G, Wolf D, Jukic E. Clonal hematopoiesis in patients with Covid-19 is stable and not linked to an aggravated clinical course. Am J Hematol 2021;96:E331-3. [PMID: 34028864 DOI: 10.1002/ajh.26251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 98 |
Vakili Sadeghi M, Firozjahi A, Bayani M, Hasanpour AH. Successful Chemotherapy of an Acute Myeloid Leukemia Case Infected with SARS-CoV-2. Int J Cancer Manag 2021;14. [DOI: 10.5812/ijcm.113003] [Reference Citation Analysis]
|
| 99 |
Nadkarni AR, Vijayakumaran SC, Gupta S, Divatia JV. Mortality in Cancer Patients With COVID-19 Who Are Admitted to an ICU or Who Have Severe COVID-19: A Systematic Review and Meta-Analysis. JCO Glob Oncol 2021;7:1286-305. [PMID: 34406802 DOI: 10.1200/GO.21.00072] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 100 |
Levy I, Lavi A, Zimran E, Grisariu S, Aumann S, Itchaki G, Berger T, Raanani P, Harel R, Aviv A, Lavi N, Zuckerman T, Shvidel L, Jarchowsky O, Ellis M, Herzog Tzarfati K, Koren-Michowitz M, Sherf Y, Levi I, Sofer O, Shpilberg O, Dally N, Suriu C, Braester A, Ben Barouch S, Leiba M, Goldstein D, Sarid N, Yeganeh S, Halloun J, Mittelman M, Tadmor T. COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome. Leuk Lymphoma 2021;62:3384-93. [PMID: 34405767 DOI: 10.1080/10428194.2021.1966782] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 101 |
Lima A, Sousa H, Nobre A, Faria AL, Machado M. The Impact of COVID-19 Pandemic in Portuguese Cancer Patients: A Retrospective Study. Int J Environ Res Public Health 2021;18:8552. [PMID: 34444302 DOI: 10.3390/ijerph18168552] [Reference Citation Analysis]
|
| 102 |
Eilami O, Lopes MIBF, Gryschek RCB, Taghipour K. A case report of COVID-19 in a patient with non-Hodgkin's lymphoma. BMC Infect Dis 2021;21:809. [PMID: 34384365 DOI: 10.1186/s12879-021-06472-2] [Reference Citation Analysis]
|
| 103 |
Rabascall CX, Lou BX, Navetta-Modrov B, Hahn SS. Effective use of monoclonal antibodies for treatment of persistent COVID-19 infection in a patient on rituximab. BMJ Case Rep 2021;14:e243469. [PMID: 34344651 DOI: 10.1136/bcr-2021-243469] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 104 |
Kifle ZD. Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review. Metabol Open 2021;11:100116. [PMID: 34345815 DOI: 10.1016/j.metop.2021.100116] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 105 |
Jani BD, Ho FK, Lowe DJ, Traynor JP, MacBride-Stewart SP, Mark PB, Mair FS, Pell JP. Comparison of COVID-19 outcomes among shielded and non-shielded populations. Sci Rep 2021;11:15278. [PMID: 34315958 DOI: 10.1038/s41598-021-94630-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 106 |
Nekooghadam SM, Moradi A, Karimi Toudeshki K, Pishgahi M. A Case of Acute Leukemia Following Remission of COVID-19 Infection; an Urge to Search for a Probable Association. Arch Acad Emerg Med 2021;9:e51. [PMID: 34405149] [Reference Citation Analysis]
|
| 107 |
Palanques-Pastor T, Megías-Vericat JE, Martínez P, López Lorenzo JL, Cornago Navascués J, Rodriguez Macias G, Cano I, Arnan Sangerman M, Vidriales Vicente MB, Algarra Algarra JL, Foncillas MÁ, Herrera P, Botella Prieto C, Vives S, Figuera Álvarez Á, Cuevas Palomares L, Sobas M, Contento Gonzalo A, Cuello García R, Amutio Diez ME, De Miguel Llorente D, Navas Elorza B, Bergua Burgues JM, Bernal Del Castillo T, Mateos Rodríguez MC, de Cabo López E, Franco Villegas AC, García Boyero R, Escolano Escobar C, Seri Merino C, Cervero C, Roldán Pérez A, Hermosín Ramos L, Cervera Calvo M, Olave MT, Villafuerte Gutiérrez P, de Laiglesiai A, Serrano J, Najera Irazu MJ, Piñana JL, Sanz MÁ, Martínez-López J, Montesinos P. Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group. Leuk Lymphoma 2021;:1-11. [PMID: 34292118 DOI: 10.1080/10428194.2021.1948031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 108 |
Alexandra VU, Sebastian W, Nathalie M, Angela L, Jean-Corentin S, Chloé S. SARS-CoV-2 infection in hematological patients during allogenic stem cell transplantation: A double case report. Clin Case Rep 2021;9:e04439. [PMID: 34295477 DOI: 10.1002/ccr3.4439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 109 |
Michot JM, Hueso T, Ibrahimi N, Pommeret F, Willekens C, Colomba E, Francis S, Bayle A, Cournède PH, Merad M, Foulon S, Albiges L, Gachot B, Barlesi F, Soria JC, Ribrag V, Griscelli F. Severe COVID-19 in patients with hematological cancers presenting with viremia. Ann Oncol 2021;32:1297-300. [PMID: 34265373 DOI: 10.1016/j.annonc.2021.07.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 110 |
Navaeian A, Mahmoudi S, Pourakbari B, Bakhtiari M, Khodabandeh M, Abdolsalehi MR, Sharari AS, Mamishi S. COVID-19 infection in children with underlying malignancies in Iran. J Basic Clin Physiol Pharmacol 2021. [PMID: 34192829 DOI: 10.1515/jbcpp-2021-0057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 111 |
Łącki S, Wyżgolik K, Nicze M, Georgiew-Nadziakiewicz S, Chudek J, Wdowiak K. Low symptomatic COVID-19 in an elderly patient with follicular lymphoma treated with rituximab-based immunotherapy: A case report. World J Clin Cases 2021; 9(18): 4859-4865 [PMID: 34222459 DOI: 10.12998/wjcc.v9.i18.4859] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 112 |
Ohara S, Fujii T, Ide S, Uchida T, Inoue M, Hagaihara M. Clinical characteristics and risk factors associated with nosocomial COVID-19 infection in patients with hematological disorders in Japan. Int J Hematol 2021. [PMID: 34152562 DOI: 10.1007/s12185-021-03172-0] [Reference Citation Analysis]
|
| 113 |
Citterio C, Lazzaro A, Bosi C, De Ponzio M, Cavanna L. Characteristics and outcomes of five patients with COVID-19 and hematological malignancies. Clin Case Rep 2021;9:e04013. [PMID: 34136224 DOI: 10.1002/ccr3.4013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 114 |
Söhn C, Bott A. [COVID-19 severity and outcomes in patients with cancer: a matched cohort study]. Strahlenther Onkol 2021;197:755-6. [PMID: 34109440 DOI: 10.1007/s00066-021-01797-y] [Reference Citation Analysis]
|
| 115 |
Başcı S, Ata N, Altuntaş F, Yiğenoğlu TN, Dal MS, Korkmaz S, Namdaroğlu S, Baştürk A, Hacıbekiroğlu T, Doğu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Çelik O, Ülgü MM, Birinci Ş; Turkish Ministry of Health, Hematology Scientific Working Group. Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers. Intern Emerg Med 2021. [PMID: 34110562 DOI: 10.1007/s11739-021-02784-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 116 |
Farooque I, Farooque U, Karimi S, Syed MUS, Nadeem Z, Zulfiqar A, Mustafa S, Farooque R, Sultan AA, Hassan SA. Clinical Presentations and Outcomes of Coronavirus Disease 2019 in Patients With Solid Tumors. Cureus 2021;13:e15452. [PMID: 34262803 DOI: 10.7759/cureus.15452] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 117 |
Marcacci G, Fiorentino G, Volzone F, Falcone U, Parrella R, Donnarumma D, D'Ovidio S, Annunziata A, Micallo G, Portella G, De Chiara A, De Filippi R, Crisci S, Pinto A. Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab. Infect Agent Cancer 2021;16:38. [PMID: 34078415 DOI: 10.1186/s13027-021-00376-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 118 |
Ljungman P, de la Camara R, Mikulska M, Tridello G, Aguado B, Zahrani MA, Apperley J, Berceanu A, Bofarull RM, Calbacho M, Ciceri F, Lopez-Corral L, Crippa C, Fox ML, Grassi A, Jimenez MJ, Demir SK, Kwon M, Llamas CV, Lorenzo JLL, Mielke S, Orchard K, Porras RP, Vallisa D, Xhaard A, Knelange NS, Cedillo A, Kröger N, Piñana JL, Styczynski J. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey. Leukemia 2021. [PMID: 34079042 DOI: 10.1038/s41375-021-01302-5] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 29.5] [Reference Citation Analysis]
|
| 119 |
Kochanek M, Böll B, Shimabukuro-vornhagen A, Eichenauer D. Infektionen bei hämatologisch-onkologischen Patienten auf der Intensivstation. Onkologie up2date 2021;3:163-177. [DOI: 10.1055/a-1382-6060] [Reference Citation Analysis]
|
| 120 |
Focosi D, Franchini M. Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations. Expert Rev Vaccines 2021;:1-8. [PMID: 34015243 DOI: 10.1080/14760584.2021.1932475] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 121 |
Tagliamento M, Agostinetto E, Bruzzone M, Ceppi M, Saini KS, de Azambuja E, Punie K, Westphalen CB, Morgan G, Pronzato P, Del Mastro L, Poggio F, Lambertini M. Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis. Crit Rev Oncol Hematol 2021;163:103365. [PMID: 34052423 DOI: 10.1016/j.critrevonc.2021.103365] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 122 |
Nair R, Kaushik MR, Kishore K, Singh HP, Vardhan V, Suresh P, Kumar M, Rathore A, Thareja S, Rana S, Bhuva D, Malviya A, Patel A. COVID-19, Cancer, and Congregation: An Observational Study from a Tertiary Care Hospital in New Delhi. Indian Journal of Medical and Paediatric Oncology 2021;42:006-10. [DOI: 10.1055/s-0041-1729732] [Reference Citation Analysis]
|
| 123 |
Zubiri L, Rosovsky RP, Mooradian MJ, Piper-Vallillo AJ, Gainor JF, Sullivan RJ, Marte D, Boland GM, Gao X, Hochberg EP, Ryan DP, McEwen C, Mai M, Sharova T, Soumerai TE, Bardia A, Reynolds KL. Temporal Trends in Inpatient Oncology Census Before and During the COVID-19 Pandemic and Rates of Nosocomial COVID-19 Among Patients with Cancer at a Large Academic Center. Oncologist 2021;26:e1427-33. [PMID: 33932247 DOI: 10.1002/onco.13807] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 124 |
Zong Z, Wei Y, Ren J, Zhang L, Zhou F. The intersection of COVID-19 and cancer: signaling pathways and treatment implications. Mol Cancer 2021;20:76. [PMID: 34001144 DOI: 10.1186/s12943-021-01363-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 125 |
Roeker LE, Knorr DA, Thompson MC, Nivar M, Lebowitz S, Peters N, Deonarine I Jr, Momotaj S, Sharan S, Chanlatte V, Hampton B, Butala L, Amato L, Richford A, Lunkenheimer J, Battiato K, Laudati C, Mato AR. COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia. Leukemia 2021;35:2703-5. [PMID: 33986431 DOI: 10.1038/s41375-021-01270-w] [Cited by in Crossref: 67] [Cited by in F6Publishing: 75] [Article Influence: 33.5] [Reference Citation Analysis]
|
| 126 |
Demichelis-Gómez R, Alvarado-Ibarra M, Vasquez-Chávez J, Delgado-López N, Gómez-Cortés C, Espinosa-Bautista K, Cooke-Tapia A, Milán-Salvatierra A, Gómez-De León A, Lee-Tsai YL, Rosales-López D, Cabrera-García Á, Amador-Medina F, Córdoba-Ramírez A, Murrieta-Álvarez I, Solís-Poblano JC, Apodaca-Chávez E, Rangel-Patiño J, Álvarez-Vera JL, Arana-Luna L, De la Peña-Celaya JA, Espitia-Ríos ME, Hernández-Ruiz E, Pérez-Zúñiga JM, Peña-López E, González-Rivera R, García-Leyva MF, Tejeda-Romero M, Cruz-Rico J, Balderas-Delgado C, Ruíz-Argüelles GJ, Gómez-Almaguer D. Treating Acute Leukemia During the COVID-19 Pandemic in an Environment With Limited Resources: A Multicenter Experience in Four Latin American Countries. JCO Glob Oncol 2021;7:577-84. [PMID: 33891480 DOI: 10.1200/GO.20.00620] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 127 |
Kim HJ, Hwang H, Hong H, Yim JJ, Lee J. A systematic review and meta-analysis of regional risk factors for critical outcomes of COVID-19 during early phase of the pandemic. Sci Rep 2021;11:9784. [PMID: 33963250 DOI: 10.1038/s41598-021-89182-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 128 |
Grever M, Andritsos L, Banerji V, Barrientos JC, Bhat S, Blachly JS, Call T, Cross M, Dearden C, Demeter J, Dietrich S, Falini B, Forconi F, Gladstone DE, Gozzetti A, Iyengar S, Johnston JB, Juliusson G, Kraut E, Kreitman RJ, Lauria F, Lozanski G, Parikh SA, Park J, Polliack A, Ravandi F, Robak T, Rogers KA, Saven A, Seymour JF, Tadmor T, Tallman MS, Tam CS, Tiacci E, Troussard X, Zent C, Zenz T, Zinzani PL, Wörmann B. Hairy cell leukemia and COVID-19 adaptation of treatment guidelines. Leukemia 2021;35:1864-72. [PMID: 33947938 DOI: 10.1038/s41375-021-01257-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 129 |
Zhang H, Han H, He T, Labbe KE, Hernandez AV, Chen H, Velcheti V, Stebbing J, Wong KK. Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review and Meta-Analysis. J Natl Cancer Inst 2021;113:371-80. [PMID: 33136163 DOI: 10.1093/jnci/djaa168] [Cited by in Crossref: 80] [Cited by in F6Publishing: 92] [Article Influence: 40.0] [Reference Citation Analysis]
|
| 130 |
Bui AN, Tyan K, Giobbie-Hurder A, Klein IA, Manos MP, Zubiri L, Reynolds K, Grover S, Weinhouse GL, Ott PA, LeBoeuf NR, Rahma O. Impact of COVID-19 on Patients with Cancer Receiving Immune Checkpoint Inhibitors. J Immunother Precis Oncol 2021;4:35-44. [PMID: 35663537 DOI: 10.36401/JIPO-20-34] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 131 |
Kaur H, Thakur JS, Paika R, Advani SM. Impact of Underlying Comorbidities on Mortality in SARS-COV-2 Infected Cancer Patients: A Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev 2021;22:1333-49. [PMID: 34048161 DOI: 10.31557/APJCP.2021.22.5.1333] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 132 |
D'Abramo A, Vita S, Maffongelli G, Mariano A, Agrati C, Castilletti C, Goletti D, Ippolito G, Nicastri E; Spallanzani COVID-19 Case Investigation Team. Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: A tailored approach. Int J Infect Dis 2021;107:247-50. [PMID: 33901654 DOI: 10.1016/j.ijid.2021.04.068] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 133 |
Yoke LH, Lee JM, Krantz EM, Morris J, Marquis S, Bhattacharyya P, So L, Riedo FX, Simmons J, Khaki AR, Cheng GS, Greninger AL, Pergam SA, Waghmare A, Ogimi C, Liu C. Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center. Open Forum Infect Dis 2021;8:ofab193. [PMID: 34183982 DOI: 10.1093/ofid/ofab193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 134 |
Mangone L, Gioia F, Mancuso P, Bisceglia I, Ottone M, Vicentini M, Pinto C, Giorgi Rossi P. Cumulative COVID-19 incidence, mortality and prognosis in cancer survivors: A population-based study in Reggio Emilia, Northern Italy. Int J Cancer 2021. [PMID: 33861870 DOI: 10.1002/ijc.33601] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 135 |
Huang Z, Ning B, Yang HS, Youngquist BM, Niu A, Lyon CJ, Beddingfield BJ, Fears AC, Monk CH, Murrell AE, Bilton SJ, Linhuber JP, Norton EB, Dietrich ML, Yee J, Lai W, Scott JW, Yin XM, Rappaport J, Robinson JE, Saba NS, Roy CJ, Zwezdaryk KJ, Zhao Z, Hu TY. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection. J Clin Invest 2021;131:146031. [PMID: 33561010 DOI: 10.1172/JCI146031] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 136 |
Papamichalis P, Tsinti G, Papapostolou E, Hadjichristodoulou C, Speletas M. Newly Diagnosed Acute Myeloid Leukemia in a Patient With Severe SARS-CoV-2 Infection. Cureus 2021;13:e14480. [PMID: 33880315 DOI: 10.7759/cureus.14480] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 137 |
Goudsmit A, Cubilier E, Meert AP, Aftimos P, Stathopoulos K, Spilleboudt C, Loizidou A. Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center study. Support Care Cancer 2021. [PMID: 33851236 DOI: 10.1007/s00520-021-06175-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 138 |
Alpert N, Taioli E. Re: Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review and Meta-Analysis. J Natl Cancer Inst 2021;113:501-2. [PMID: 33681972 DOI: 10.1093/jnci/djab030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 139 |
Wang LQ, Tan Su Yin E, Wei GQ, Hu YX, Nagler A, Huang H. Weathering the storm: COVID-19 infection in patients with hematological malignancies. J Zhejiang Univ Sci B 2020;21:921-39. [PMID: 33843158 DOI: 10.1631/jzus.B2000423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 140 |
Bora VR, Patel BM. The Deadly Duo of COVID-19 and Cancer! Front Mol Biosci 2021;8:643004. [PMID: 33912588 DOI: 10.3389/fmolb.2021.643004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 141 |
Cantini L, Bastianelli L, Lupi A, Pinterpe G, Pecci F, Belletti G, Stoico R, Vitarelli F, Moretti M, Onori N, Giampieri R, Rocchi MBL, Berardi R. Seroprevalence of SARS-CoV-2-Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy. J Clin Med 2021;10:1503. [PMID: 33916569 DOI: 10.3390/jcm10071503] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 142 |
Kochanek M, Böll B, Shimabukuro-vornhagen A, Eichenauer D. Infektionen bei hämatologisch-onkologischen Patienten auf der Intensivstation. TumorDiagnostik & Therapie 2021;42:209-220. [DOI: 10.1055/a-1361-7423] [Reference Citation Analysis]
|
| 143 |
Lam C, Siefkas A, Zelin NS, Barnes G, Dellinger RP, Vincent JL, Braden G, Burdick H, Hoffman J, Calvert J, Mao Q, Das R. Machine Learning as a Precision-Medicine Approach to Prescribing COVID-19 Pharmacotherapy with Remdesivir or Corticosteroids. Clin Ther 2021:S0149-2918(21)00128-4. [PMID: 33865643 DOI: 10.1016/j.clinthera.2021.03.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 144 |
Franco F, Guirado M, Martínez-Banaclocha N, Gumà J, Lavernia J, Gómez-Codina J, Rodriguez-Abreu D, Martínez F, Barrajón E, Méndez M, Calvo V, Provencio M. Multicenter Study of the Seroprevalence of Antibodies against Covid-19 in Patients with Lymphoma: An Analysis of the Oncological Group for the Treatment and Study of Lymphomas (Gotel). Curr Oncol 2021;28:1249-55. [PMID: 33809772 DOI: 10.3390/curroncol28020118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 145 |
Xiao H, Luo Y, Shi J, Jin A, Mohty M, Nagler A, Gale RP, Huang H. How Do We Manage Hematopoietic Cell Transplant during the SARS-CoV-2 Pandemic? Acta Haematol 2021;144:500-7. [PMID: 33690228 DOI: 10.1159/000513036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 146 |
Butt A, Ali N. COVID-19 and adult acute lymphoblastic leukemia: Presentation and management. Hematol Transfus Cell Ther 2021;43:219-21. [PMID: 33681710 DOI: 10.1016/j.htct.2021.01.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 147 |
Wiggill TM, Mayne ES, Vaughan JL, Louw S. Overview of the Haematological Effects of COVID-19 Infection. Adv Exp Med Biol 2021;1321:163-72. [PMID: 33656722 DOI: 10.1007/978-3-030-59261-5_14] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 148 |
Hong YS. COVID-19 and Cancer: Questions to Be Answered. Korean J Hosp Palliat Care 2021;24:66-68. [DOI: 10.14475/jhpc.2021.24.1.66] [Reference Citation Analysis]
|
| 149 |
Liu W, Li Z, He W, Yu D, Wang P, Cai L, Yang P, Chen X, Zhang X, Zhou H. Impact of chemotherapy on lymphocytes and serological memory in recovered COVID-19 patients with acute leukemia. J Cancer 2021;12:2450-5. [PMID: 33758621 DOI: 10.7150/jca.53863] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 150 |
Langerbeins P, Eichhorst B. Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic. Acta Haematol 2021;144:508-18. [PMID: 33631756 DOI: 10.1159/000514071] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 151 |
Venkatesulu BP, Chandrasekar VT, Girdhar P, Advani P, Sharma A, Elumalai T, Hsieh CE, Elghazawy HI, Verma V, Krishnan S. A Systematic Review and Meta-Analysis of Cancer Patients Affected by a Novel Coronavirus. JNCI Cancer Spectr 2021;5:pkaa102. [PMID: 33875976 DOI: 10.1093/jncics/pkaa102] [Cited by in Crossref: 30] [Cited by in F6Publishing: 39] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 152 |
Rahman A, Niloofa R, Jayarajah U, De Mel S, Abeysuriya V, Seneviratne SL. Hematological Abnormalities in COVID-19: A Narrative Review. Am J Trop Med Hyg 2021:tpmd201536. [PMID: 33606667 DOI: 10.4269/ajtmh.20-1536] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 153 |
Ormazabal Vélez I, Induráin Bermejo J, Espinoza Pérez J, Imaz Aguayo L, Delgado Ruiz M, García-Erce JA. Two patients with rituximab associated low gammaglobulin levels and relapsed covid-19 infections treated with convalescent plasma. Transfus Apher Sci 2021;60:103104. [PMID: 33637467 DOI: 10.1016/j.transci.2021.103104] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 154 |
Maurer K, Saucier A, Kim HT, Acharya U, Mo CC, Porter J, Albert C, Cutler C, Antin JH, Koreth J, Gooptu M, Romee R, Wu CJ, Soiffer RJ, Nikiforow S, Jacobson C, Ho VT. COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience. Blood Adv 2021;5:861-71. [PMID: 33560397 DOI: 10.1182/bloodadvances.2020003883] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 155 |
Regalado-Artamendi I, Jiménez-Ubieto A, Hernández-Rivas JÁ, Navarro B, Núñez L, Alaez C, Córdoba R, Peñalver FJ, Cannata J, Estival P, Quiroz-Cervantes K, Riaza Grau R, Velasco A, Martos R, Domingo-González A, Benito-Parra L, Gómez-Sanz E, López-Jiménez J, Matilla A, Herraez MR, Penalva MJ, García-Suárez J, Díez-Martín JL, Bastos-Oreiro M. Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study. Hemasphere 2021;5:e538. [PMID: 33604516 DOI: 10.1097/HS9.0000000000000538] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 156 |
Vijenthira A, Gong IY, Fox TA, Booth S, Cook G, Fattizzo B, Martín-Moro F, Razanamahery J, Riches JC, Zwicker J, Patell R, Vekemans MC, Scarfò L, Chatzikonstantinou T, Yildiz H, Lattenist R, Mantzaris I, Wood WA, Hicks LK. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood 2020;136:2881-92. [PMID: 33113551 DOI: 10.1182/blood.2020008824] [Cited by in Crossref: 275] [Cited by in F6Publishing: 291] [Article Influence: 137.5] [Reference Citation Analysis]
|
| 157 |
Li H, Baldwin E, Zhang X, Kenost C, Luo W, Calhoun EA, An L, Bennett CL, Lussier YA. COVID-19 increases age- and sex-controlled 21-day fatality rates for patients with melanoma, hematologic malignancies, uterine cancer, or kidney cancer.. [DOI: 10.1101/2021.02.06.21251099] [Reference Citation Analysis]
|
| 158 |
Xhaard A, Xhaard C, D'Aveni M, Salvator H, Chabi ML, Berceanu A, Coman T, Beguin Y, Chalandon Y, Poiré X, Loschi M, Paillard C, Bruno B, Ceballos P, Dalle JH, Bilger K, Bay JO, Robin M, N'Guyen-Quoc S, Rubio MT. Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study. Br J Haematol 2021;192:e121-4. [PMID: 33522598 DOI: 10.1111/bjh.17260] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 159 |
Tugce N. Yigenoglu, Naim Ata, Fevzi Altuntas, Semih Bascı, Mehmet Sinan Dal, Serdal Korkmaz, Sinem Namdaroglu, Abdulkadir Basturk, Tuba Hacıbekiroglu, Mehmet H. Dogu, İlhami Berber, Kursat Dal, Mehmet A. Erkurt, Burhan Turgut, Mustafa Mahir Ulgu, Osman Celik, Ersan Imrat, Suayip Birinci. The outcome of COVID‐19 in patients with hematological malignancy. J Med Virol 2021;93. [PMID: 32776581 DOI: 10.1002/jmv.26404] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 34.0] [Reference Citation Analysis]
|
| 160 |
Fung M, Babik JM. COVID-19 in Immunocompromised Hosts: What We Know So Far. Clin Infect Dis. 2021;72:340-350. [PMID: 33501974 DOI: 10.1093/cid/ciaa863] [Cited by in Crossref: 222] [Cited by in F6Publishing: 254] [Article Influence: 111.0] [Reference Citation Analysis]
|
| 161 |
Bhogal T, Khan UT, Lee R, Stockdale A, Hesford C, Potti-Dhananjaya V, Jathanna A, Rahman S, Tivey A, Shotton R, Sundar R, Valerio C, Norouzi A, Walker P, Suckling R, Armstrong A, Brearton G, Pettitt A, Kalakonda N, Palmer DH, Jackson R, Turtle L, Palmieri C. Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort. Leuk Lymphoma 2021;62:1682-91. [PMID: 33508995 DOI: 10.1080/10428194.2021.1876865] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 162 |
Barcellini W, Giannotta JA, Fattizzo B. Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature. Front Immunol 2020;11:609198. [PMID: 33574816 DOI: 10.3389/fimmu.2020.609198] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 163 |
Mehta A, Vasudevan S, Parkash A, Sharma A, Vashist T, Krishna V. COVID-19 mortality in cancer patients: a report from a tertiary cancer centre in India. PeerJ 2021;9:e10599. [PMID: 33552716 DOI: 10.7717/peerj.10599] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 164 |
Barbosa JR, de Carvalho Junior RN. Polysaccharides obtained from natural edible sources and their role in modulating the immune system: Biologically active potential that can be exploited against COVID-19. Trends Food Sci Technol 2021;108:223-35. [PMID: 33424125 DOI: 10.1016/j.tifs.2020.12.026] [Cited by in Crossref: 46] [Cited by in F6Publishing: 54] [Article Influence: 23.0] [Reference Citation Analysis]
|
| 165 |
Phillips T, Stammers M, Leggatt G, Bonfield B, Fraser S, Armstrong K, Veighey K. Acute kidney injury in COVID‐19: Identification of risk factors and potential biomarkers of disease in a large UK cohort. Nephrology 2021;26:420-31. [DOI: 10.1111/nep.13847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 166 |
Langford BJ, So M, Raybardhan S, Leung V, Soucy JR, Westwood D, Daneman N, MacFadden DR. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect 2021;27:520-31. [PMID: 33418017 DOI: 10.1016/j.cmi.2020.12.018] [Cited by in Crossref: 221] [Cited by in F6Publishing: 249] [Article Influence: 110.5] [Reference Citation Analysis]
|
| 167 |
Wolf J, Abzug MJ, Wattier RL, Sue PK, Vora SB, Zachariah P, Dulek DE, Waghmare A, Olivero R, Downes KJ, James SH, Pinninti SG, Yarbrough A, Aldrich ML, MacBrayne CE, Soma VL, Grapentine SP, Oliveira CR, Hayes M, Kimberlin DW, Jones SB, Bio LL, Morton TH, Hankins JS, Maron GM, Timberlake K, Young JL, Orscheln RC, Schwenk HT, Goldman DL, Groves HE, Huskins WC, Rajapakse NS, Lamb GS, Tribble AC, Lloyd EC, Hersh AL, Thorell EA, Ratner AJ, Chiotos K, Nakamura MM. Initial Guidance on Use of Monoclonal Antibody Therapy for Treatment of Coronavirus Disease 2019 in Children and Adolescents. J Pediatric Infect Dis Soc 2021;10:629-34. [PMID: 33388760 DOI: 10.1093/jpids/piaa175] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 20.0] [Reference Citation Analysis]
|
| 168 |
Laurenge A, Ursu R, Houillier C, Abdi B, Tebano G, Quemeneur C, Choquet S, Di Blasi R, Lozano F, Morales A, Durán-Peña A, Sirven-Villaros L, Mathon B, Mokhtari K, Bielle F, Martin-Duverneuil N, Delattre JY, Marcelin AG, Pourcher V, Alentorn A, Idbaih A, Carpentier AF, Leblond V, Hoang-Xuan K, Touat M. SARS-CoV-2 infection in patients with primary central nervous system lymphoma. J Neurol 2021;268:3072-80. [PMID: 33387015 DOI: 10.1007/s00415-020-10311-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 169 |
Karki NR, Le T, Cortes J. The Care of the Leukemic Patients in Times of SARS-CoV-2. Curr Oncol Rep 2021;23:114. [PMID: 34342734 DOI: 10.1007/s11912-021-01111-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 170 |
Lupo-Stanghellini MT, Xue E, Mastaglio S, Oltolini C, Angelillo P, Messina C, Piemontese S, Girlanda S, Farina F, Lazzari L, Cicalese MP, Erbella F, Greco R, Locatelli M, Milani R, Peccatori J, Corti C, Marktel S, Assanelli A, Ciceri F. COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome. Bone Marrow Transplant 2021;56:2312-5. [PMID: 34193980 DOI: 10.1038/s41409-021-01278-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 171 |
Silva TTMD, Araújo NMD, Sarmento SDG, Castro GLTD, Dantas DV, Dantas RAN. IMPACT OF COVID-19 IN PATIENTS WITH CANCER: A SCOPING REVIEW. Texto contexto - enferm 2021;30. [DOI: 10.1590/1980-265x-tce-2020-0415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 172 |
Todd KH. COVID-19. Oncologic Emergency Medicine 2021. [DOI: 10.1007/978-3-030-67123-5_70] [Reference Citation Analysis]
|
| 173 |
Fakharian A, Ebrahimibagha H, Mirenayat MS, Farahmandi F. COVID-19 Reinfection in a Patient with Hodgkin Lymphoma: a Case Report. Tanaffos 2021;20:71-4. [PMID: 34394373] [Reference Citation Analysis]
|
| 174 |
Höllein A, Bojko P, Schulz S, Neitz J, Stötzer O, Pihusch R, Abedinpour F, Schmidt B, Hentrich M. Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study. Acta Oncol 2021;60:24-7. [PMID: 33397179 DOI: 10.1080/0284186X.2020.1863464] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 175 |
Greco R, Alexander T, Burman J, Del Papa N, de Vries-Bouwstra J, Farge D, Henes J, Kazmi M, Kirgizov K, Muraro PA, Ricart E, Rovira M, Saccardi R, Sharrack B, Snarski E, Withers B, Jessop H, Boglione C, Kramer E, Badoglio M, Labopin M, Orchard K, Corbacioglu S, Ljungman P, Mikulska M, De la Camara R, Snowden JA; European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), Infectious Diseases Working Party (IDWP), Pediatric Working Party (PWP), Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE), EBMT Nurses Group and Patient Advocacy Committee. Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations. Bone Marrow Transplant 2021;56:1493-508. [PMID: 34031556 DOI: 10.1038/s41409-021-01326-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 176 |
Danilenko AA, Shakhtarina S, Falaleeva N. COVID-19 in Patients with Oncohematological Diseases. Клиническая онкогематология 2021;14:220-224. [DOI: 10.21320/2500-2139-2021-14-2-220-224] [Reference Citation Analysis]
|
| 177 |
Botti S, Serra N, Castagnetti F, Chiaretti S, Mordini N, Gargiulo G, Orlando L. Hematology Patient Protection During the COVID-19 Pandemic in Italy: A Nationwide Nursing Survey. Mediterr J Hematol Infect Dis 2021;13:e2021011. [PMID: 33489050 DOI: 10.4084/MJHID.2021.011] [Reference Citation Analysis]
|
| 178 |
Akinosoglou K, Paliogianni F, Spyridonidis A, Symeonidis A, Alexopoulos LG, Ziazias D, Kouraklis-Symeonidis A, Marangos M, Gogos C. SARS-CoV-2 persistence and non-protective immunity in infected haematological patients. Br J Haematol 2021;192:e51-4. [PMID: 33216364 DOI: 10.1111/bjh.17212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 179 |
Karimi M, Haghpanah S, Azarkeivan A, Matin S, Safaei A, De Sanctis V. Coronavirus Disease 2019 (COVID-19) Severity in Patients with Thalassemias: A Nationwide Iranian Experience. Mediterr J Hematol Infect Dis 2021;13:e2021008. [PMID: 33489047 DOI: 10.4084/MJHID.2021.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 180 |
El Fakih R, Haroon A, Alfraih F, Al-Khabori MK, Alzahrani M, Alhuraiji A, Hamadah A, AlJohani NI, Alahmari B, Essa MF, Motabi IH, Tailor IK, Almaghrabi RS, Al-Farsi K, Abosoudah I, Ayas M, Elhassan TA, Suhebeh AM, Ahmed SO, Alhayli S, Kaloyannidis P, Alsaeed A, Anezi KA, Alamoudi S, Damlaj M, Hashmi HA, Aljurf M. Clinical course and outcomes of COVID-19 in hematopoietic cell transplant patients, a regional report from the Middle East. Bone Marrow Transplant 2021;56:2144-51. [PMID: 33907304 DOI: 10.1038/s41409-021-01312-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 181 |
Sica A, Casale D, Rossi G, Casale B, Ciccozzi M, Fasano M, Ciotti M, Sagnelli E, Papa A, Sagnelli C. The impact of the SARS-CoV-2 infection, with special reference to the hematological setting. J Med Virol 2021;93:223-33. [PMID: 32558961 DOI: 10.1002/jmv.26197] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 182 |
Lotfy SM, Abbas A, Shouman W. Use of Hydroxychloroquine in Patients with COVID-19: A Retrospective Observational Study. Turk Thorac J 2021;22:62-6. [PMID: 33646106 DOI: 10.5152/TurkThoracJ.2021.20180] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 183 |
Bestilleiro RS, Señaris DM, Rodríguez MJP, Vázquez RG, Rodríguez RG, Rodriguez MTG, Martín CG, Pillado MTS, Barreiro VB, Valiña VV, Díaz SP. Nosocomial Infection Outbreak due to SARS-COV-2 in a Hospital Unit of Particularly Vulnerable Patients. Int J Med Sci 2021;18:2146-54. [PMID: 33859521 DOI: 10.7150/ijms.53270] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 184 |
Avanzato VA, Matson MJ, Seifert SN, Pryce R, Williamson BN, Anzick SL, Barbian K, Judson SD, Fischer ER, Martens C, Bowden TA, de Wit E, Riedo FX, Munster VJ. Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer. Cell 2020;183:1901-1912.e9. [PMID: 33248470 DOI: 10.1016/j.cell.2020.10.049] [Cited by in Crossref: 458] [Cited by in F6Publishing: 457] [Article Influence: 152.7] [Reference Citation Analysis]
|
| 185 |
Hus I, Salomon-Perzyński A, Tomasiewicz K, Robak T. The management of hematologic malignancies during the COVID-19 pandemic. Expert Opin Pharmacother 2021;22:565-82. [PMID: 33342308 DOI: 10.1080/14656566.2020.1849143] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 186 |
Maia C, Martín-Sánchez E, Garcés JJ, De Cerio AL, Inogés S, Landecho MF, Gil-Alzugaray B, Perez C, Botta C, Zabaleta A, Alegre F, Rincón C, Blanco L, Sarvide S, Vilas-Zornoza A, Alignani D, Moreno C, Paiva A, Martinho A, Alves R, Colado E, Quirós C, Olid M, Blanco A, Argemi J, Paiva B, Yuste JR. Immunologic characterization of COVID-19 patients with hematological cancer. Haematologica 2020;106:1457-60. [PMID: 33327714 DOI: 10.3324/haematol.2020.269878] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 187 |
Rajasurya V, Elliott K, Dugan J, Moreb JS. COVID-19 in patients with acute leukemia: Two cases with different outcomes. Leuk Res Rep 2021;15:100232. [PMID: 33318925 DOI: 10.1016/j.lrr.2020.100232] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 188 |
Ghandili S, Pfefferle S, Roedl K, Sonnemann P, Karagiannis P, Boenisch O, Kluge S, Schmiedel S, Ittrich H, Rohde H, Lütgehetmann M, Weisel K, Bokemeyer C, Wichmann D, Fiedler W, Jarczak D, Modemann F. Challenges in treatment of patients with acute leukemia and COVID-19: a series of 12 patients. Blood Adv 2020;4:5936-41. [PMID: 33275765 DOI: 10.1182/bloodadvances.2020002543] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 189 |
Worel N, Shaw BE, Aljurf M, Koh M, Seber A, Weisdorf D, Schwartz J, Galeano S, Kodera Y, Eldridge PW, Hashmi S, Atsuta Y, Szer J, Saber W, Niederwieser D, Greinix HT; Worldwide Network for Blood & Marrow Transplantation. Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation. Transplant Cell Ther 2021;27:270.e1-6. [PMID: 33781537 DOI: 10.1016/j.jtct.2020.11.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 190 |
Tafti D, Kluckman M, Dearborn MC, Hunninghake J, Clayton S. COVID-19 in Patients With Hematologic-Oncologic Risk Factors: Complications in Three Patients. Cureus 2020;12:e12064. [PMID: 33489484 DOI: 10.7759/cureus.12064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 191 |
Borah P, Mirgh S, Sharma SK, Bansal S, Dixit A, Dolai TK, Lunkad S, Gupta N, Singh G, Jain A, Bansal D, Choudhary D, Khandelwal V, Doval D, Kumar M, Bhargava R, Chakrabarti A, Kalashetty M, Rauthan A, Kazi B, Mandal PK, Jeyaraman P, Naithani R; AIIMS Hematology Alumni Group. Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies. Blood Cells Mol Dis 2021;87:102525. [PMID: 33338697 DOI: 10.1016/j.bcmd.2020.102525] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 192 |
Sun C, Li J, Xiang H, Li C, Shang A, Chang W, Gui X, Wang Y, Wang H, Cheng Q, Zhang C, Yuan G, Wan C, Liu Q, Wang L, Huang Z, Liang C, Wu Y, Hu Y. COVID-19 in patients with multiple myeloma: a cross-sectional survey from the most severely affected region in China. Leuk Lymphoma 2021;62:731-4. [PMID: 33269626 DOI: 10.1080/10428194.2020.1834098] [Reference Citation Analysis]
|
| 193 |
Giuliani J, Bonetti A. COVID-19 and cancer: A clear change not only in daily clinical practice but also in clinical research management. J Med Virol 2021;93:2564-5. [PMID: 33215735 DOI: 10.1002/jmv.26680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 194 |
Wang F, Huang L, Zhang P, Si Y, Yu J, Ding B. Antibacterial N-halamine fibrous materials. Composites Communications 2020;22:100487. [DOI: 10.1016/j.coco.2020.100487] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 195 |
Tsatsakis A, Calina D, Falzone L, Petrakis D, Mitrut R, Siokas V, Pennisi M, Lanza G, Libra M, Doukas SG, Doukas PG, Kavali L, Bukhari A, Gadiparthi C, Vageli DP, Kofteridis DP, Spandidos DA, Paoliello MMB, Aschner M, Docea AO. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19. Food Chem Toxicol 2020;146:111769. [PMID: 32979398 DOI: 10.1016/j.fct.2020.111769] [Cited by in Crossref: 90] [Cited by in F6Publishing: 99] [Article Influence: 30.0] [Reference Citation Analysis]
|
| 196 |
Fung M, Nambiar A, Pandey S, Aldrich JM, Teraoka J, Freise C, Roberts J, Chandran S, Hays SR, Bainbridge E, DeVoe C, Roque Gardner A, Yokoe D, Henrich TJ, Babik JM, Chin-Hong P. Treatment of immunocompromised COVID-19 patients with convalescent plasma. Transpl Infect Dis 2021;23:e13477. [PMID: 32989856 DOI: 10.1111/tid.13477] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 197 |
Lee H, Tay J, Duggan P, McCulloch S, Neri P, Bahlis NJ, Jimenez-Zepeda VH. The impact of COVID-19 in the management of AL amyloidosis and Immunoglobulin Deposition Disease: A single-center experience. Eur J Haematol 2021;106:340-5. [PMID: 33197297 DOI: 10.1111/ejh.13552] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 198 |
Clark JJ, Dwyer D, Pinwill N, Clark P, Johnson P, Hackshaw A. The effect of clinical decision making for initiation of systemic anticancer treatments in response to the COVID-19 pandemic in England: a retrospective analysis. Lancet Oncol 2021;22:66-73. [PMID: 33253639 DOI: 10.1016/S1470-2045(20)30619-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 199 |
Mahimainathan L, Narasimhan M, Corchado R, Patel H, Kansagra A, Devaraj S, Geethakumari PR, Muthukumar A. Evaluation of SARS-CoV-2 Serological Testing in Patients with Multiple Myeloma and Other Hematologic Malignancies on Monoclonal Antibody Therapies. Diagnostics (Basel) 2020;10:E992. [PMID: 33255154 DOI: 10.3390/diagnostics10120992] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 200 |
Monreal E, Sainz de la Maza S, Fernández-Velasco JI, Natera-Villalba E, Rita CG, Rodríguez-Jorge F, Beltrán-Corbellini Á, Iturrieta-Zuazo I, Rodríguez de Santiago E, Espiño M, de Andrés A, Fortún J, Barbero E, Vázquez M, Fernández Lucas M, Manzano L, Montero-Errasquín B, Costa-Frossard L, Masjuan J, Villar LM; COVID-HRC group. The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19. J Clin Immunol 2021;41:315-23. [PMID: 33236261 DOI: 10.1007/s10875-020-00927-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 201 |
Nakamura S, Kanemasa Y, Atsuta Y, Fujiwara S, Tanaka M, Fukushima K, Kobayashi T, Shimoyama T, Omuro Y, Sekiya N, Imamura A. Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan. Int J Clin Oncol 2021;26:485-93. [PMID: 33225396 DOI: 10.1007/s10147-020-01837-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 202 |
Monreal E, Maza S S, Gullón P, Natera-Villalba E, Chico-García JL, Beltrán-Corbellini Á, Martínez-Sanz J, García-Barragán N, Buisán J, Toledano R, Alonso-Canovas A, Pérez-Torre P, Matute-Lozano MC, López-Sendón JL, García-Ribas G, Corral Í, Fortún J, Montero-Errasquín B, Manzano L, Máiz-Carro L, Costa-Frossard L, Masjuan J; COVID-HRC Group. Non-severe immunosuppression might be associated with a lower risk of moderate-severe acute respiratory distress syndrome in COVID-19: A pilot study. J Med Virol 2021;93:2243-51. [PMID: 33165922 DOI: 10.1002/jmv.26656] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 203 |
Mangone L, Gioia F, Mancuso P, Bisceglia I, Ottone M, Vicentini M, Pinto C, Rossi PG. Cumulative COVID-19 incidence, mortality, and prognosis in cancer survivors: a population-based study in Reggio Emilia, Northern Italy.. [DOI: 10.1101/2020.11.18.20233833] [Reference Citation Analysis]
|
| 204 |
Pelcovits A, Pandita A, Farmakiotis D, Egan P. Lymphocyte-depleting chemotherapy for aggressive hematologic malignancies in two patients with positive SARS-CoV-2 PCR. Leuk Res 2021;100:106473. [PMID: 33285314 DOI: 10.1016/j.leukres.2020.106473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 205 |
Mounir L, Mehdi S, Kawtar F, Akram M, Youness ET, Meryem T, Othmane JT, Imane E, Hanane E, Boubakar C, Marieme C, Mouna L, Asmaa H, Asmaa Q. Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report. Pan Afr Med J 2020;37:34. [PMID: 33456658 DOI: 10.11604/pamj.supp.2020.37.34.25501] [Reference Citation Analysis]
|
| 206 |
Mounir L, Mehdi S, Kawtar F, Akram M, Youness ET, Meryem T, Othmane JT, Imane E, Hanane E, Boubakar C, Marieme C, Mouna L, Asmaa H, Asmaa Q. Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case report. Pan Afr Med J 2020;37:34. [PMID: 33456658 DOI: 10.11604/pamj.supp.2020.37.34.25501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 207 |
Aliabadi F, Ajami M, Pazoki–toroudi H. Why does COVID‐19 pathology have several clinical forms? BioEssays 2020;42:2000198. [DOI: 10.1002/bies.202000198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 208 |
Quagliariello V, Bonelli A, Caronna A, Conforti G, Iovine M, Carbone A, Berretta M, Botti G, Maurea N. SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients. Cancers (Basel) 2020;12:E3316. [PMID: 33182653 DOI: 10.3390/cancers12113316] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 209 |
Bakouny Z, Hawley JE, Choueiri TK, Peters S, Rini BI, Warner JL, Painter CA. COVID-19 and Cancer: Current Challenges and Perspectives. Cancer Cell 2020;38:629-46. [PMID: 33049215 DOI: 10.1016/j.ccell.2020.09.018] [Cited by in Crossref: 150] [Cited by in F6Publishing: 126] [Article Influence: 50.0] [Reference Citation Analysis]
|
| 210 |
Wang Q, Berger NA, Xu R. When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities. Blood Rev 2021;47:100775. [PMID: 33187811 DOI: 10.1016/j.blre.2020.100775] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 211 |
Garnett C, Foldes D, Bailey C, Nesr G, Hui T, Hinton R, Gurung K, Phillips J, Saleem Z, Koshy R, Aduwa E, Colis M, Bimolah R, Katsomitrou V, Arami S, Kagdi H. Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom. Leuk Lymphoma. 2021;62:469-472. [PMID: 33167718 DOI: 10.1080/10428194.2020.1838506] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 212 |
Rüthrich MM, Giessen-Jung C, Borgmann S, Classen AY, Dolff S, Grüner B, Hanses F, Isberner N, Köhler P, Lanznaster J, Merle U, Nadalin S, Piepel C, Schneider J, Schons M, Strauss R, Tometten L, Vehreschild JJ, von Lilienfeld-Toal M, Beutel G, Wille K; LEOSS Study Group. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry. Ann Hematol 2021;100:383-93. [PMID: 33159569 DOI: 10.1007/s00277-020-04328-4] [Cited by in Crossref: 79] [Cited by in F6Publishing: 59] [Article Influence: 26.3] [Reference Citation Analysis]
|
| 213 |
Nie L, Dai K, Wu J, Zhou X, Hu J, Zhang C, Zhan Y, Song Y, Fan W, Hu Z, Yang H, Yang Q, Wu D, Li F, Li D, Nie R. Clinical characteristics and risk factors for in-hospital mortality of lung cancer patients with COVID-19: A multicenter, retrospective, cohort study. Thorac Cancer 2021;12:57-65. [PMID: 33142039 DOI: 10.1111/1759-7714.13710] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 214 |
Liu Y, Lu H, Wang W, Liu Q, Zhu C. Clinical risk factors for mortality in patients with cancer and COVID-19: a systematic review and meta-analysis of recent observational studies. Expert Rev Anticancer Ther 2021;21:107-19. [PMID: 33054414 DOI: 10.1080/14737140.2021.1837628] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 215 |
Kochanek M, Böll B, Shimabukuro-vornhagen A, Eichenauer D. Infektionen bei hämatologisch-onkologischen Patienten auf der Intensivstation. Intensivmedizin up2date 2020;16:399-413. [DOI: 10.1055/a-1192-8742] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 216 |
Sperotto A, Candoni A, Petruzzellis G, Mullai R, Patriarca F, Tascini C, Fanin R. Screening procedure for SARS-CoV-2 infection combining triage, nasopharyngeal swab and serological test in allogeneic stem cell transplantation recipients undergoing outpatient posttransplant follow-up. J Med Virol 2021;93:1244-6. [PMID: 33030745 DOI: 10.1002/jmv.26586] [Reference Citation Analysis]
|
| 217 |
Kamaz B, Mullally A. COVID-19 and myeloproliferative neoplasms: some considerations. Leukemia 2021;35:279-81. [PMID: 33106624 DOI: 10.1038/s41375-020-01070-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 218 |
Monreal E, Sainz de la Maza S, Natera-Villalba E, Beltrán-Corbellini Á, Rodríguez-Jorge F, Fernández-Velasco JI, Walo-Delgado P, Muriel A, Zamora J, Alonso-Canovas A, Fortún J, Manzano L, Montero-Errasquín B, Costa-Frossard L, Masjuan J, Villar LM; COVID-HRC group. High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study. Eur J Clin Microbiol Infect Dis 2021;40:761-9. [PMID: 33083917 DOI: 10.1007/s10096-020-04078-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 219 |
Luetkens T, Metcalf R, Planelles V, Zheng Y, Larragoite ET, Spivak ES, Spivak AM, Steinbach M, Blaylock RC, Avila SV, Hankey KG, Martins TB, Slev PR, Mannuel HD, Sajadi M, Rapoport AP, Atanackovic D. Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19. Blood Adv 2020;4:4864-8. [PMID: 33031540 DOI: 10.1182/bloodadvances.2020002595] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 220 |
Osterman CK, Triglianos T, Winzelberg GS, Nichols AD, Rodriguez-O'Donnell J, Bigelow SM, van Deventer H, Sanoff HK, Ray EM. Risk stratification and outreach to hematology/oncology patients during the COVID-19 pandemic. Support Care Cancer 2021;29:1161-4. [PMID: 33047163 DOI: 10.1007/s00520-020-05744-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 221 |
García-Suárez J, de la Cruz J, Cedillo Á, Llamas P, Duarte R, Jiménez-Yuste V, Hernández-Rivas JÁ, Gil-Manso R, Kwon M, Sánchez-Godoy P, Martínez-Barranco P, Colás-Lahuerta B, Herrera P, Benito-Parra L, Alegre A, Velasco A, Matilla A, Aláez-Usón MC, Martos-Martínez R, Martínez-Chamorro C, Susana-Quiroz K, Del Campo JF, de la Fuente A, Herráez R, Pascual A, Gómez E, Pérez-Oteyza J, Ruiz E, Alonso A, González-Medina J, Martín-Buitrago LN, Canales M, González-Gascón I, Vicente-Ayuso MC, Valenciano S, Roa MG, Monteliu PE, López-Jiménez J, Escobar CE, Ortiz-Martín J, Diez-Martin JL, Martinez-Lopez J; Asociación Madrileña de Hematología y Hemoterapia (AMHH). Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study. J Hematol Oncol 2020;13:133. [PMID: 33032660 DOI: 10.1186/s13045-020-00970-7] [Cited by in Crossref: 108] [Cited by in F6Publishing: 112] [Article Influence: 36.0] [Reference Citation Analysis]
|
| 222 |
Lotfali E, Ghasemi R, Mardani M, Fattahi A, Rezaei K, Toreyhi H, Abolghasemi S. A Review on Hematologic Malignant Patients Infected with 2019 Novel Coronavirus. Arch Clin Infect Dis 2020;15. [DOI: 10.5812/archcid.107788] [Reference Citation Analysis]
|
| 223 |
Stanworth SJ, New HV, Apelseth TO, Brunskill S, Cardigan R, Doree C, Germain M, Goldman M, Massey E, Prati D, Shehata N, So-Osman C, Thachil J. Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol 2020;7:e756-64. [PMID: 32628911 DOI: 10.1016/S2352-3026(20)30186-1] [Cited by in Crossref: 150] [Cited by in F6Publishing: 149] [Article Influence: 50.0] [Reference Citation Analysis]
|
| 224 |
Teckie S, Koffler D, Potters L. The Resilience of Radiation Oncology in the COVID Era and Beyond. Int J Radiat Oncol Biol Phys 2020;108:364-9. [PMID: 32890514 DOI: 10.1016/j.ijrobp.2020.06.065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 225 |
Lee LYW, Cazier JB, Starkey T, Briggs SEW, Arnold R, Bisht V, Booth S, Campton NA, Cheng VWT, Collins G, Curley HM, Earwaker P, Fittall MW, Gennatas S, Goel A, Hartley S, Hughes DJ, Kerr D, Lee AJX, Lee RJ, Lee SM, Mckenzie H, Middleton CP, Murugaesu N, Newsom-Davis T, Olsson-Brown AC, Palles C, Powles T, Protheroe EA, Purshouse K, Sharma-Oates A, Sivakumar S, Smith AJ, Topping O, Turnbull CD, Várnai C, Briggs ADM, Middleton G, Kerr R; UK Coronavirus Cancer Monitoring Project Team. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol 2020;21:1309-16. [PMID: 32853557 DOI: 10.1016/S1470-2045(20)30442-3] [Cited by in Crossref: 359] [Cited by in F6Publishing: 374] [Article Influence: 119.7] [Reference Citation Analysis]
|
| 226 |
Lamure S, Duléry R, Di Blasi R, Chauchet A, Laureana C, Deau-Fischer B, Drenou B, Soussain C, Rossi C, Noël N, Choquet S, Bologna S, Joly B, Kohn M, Malak S, Fouquet G, Daguindau E, Bernard S, Thiéblemont C, Cartron G, Lacombe K, Besson C. Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study. EClinicalMedicine 2020;27:100549. [PMID: 33073216 DOI: 10.1016/j.eclinm.2020.100549] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 227 |
Zhang LL, Liu Y, Guo YG, Chang J, Gao B, Li ZZ, Geng W, Hu P, Song B, Zhang X, Wan CC. Convalescent Plasma Rescued a Severe COVID-19 Patient with Chronic Myeloid Leukemia Blast Crisis and Myelofibrosis. Turk J Haematol 2021;18:74-6. [PMID: 32988811 DOI: 10.4274/tjh.galenos.2020.2020.0400] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 228 |
Glenthøj A, Jakobsen LH, Sengeløv H, Ahmad SA, Qvist K, Rewes A, Poulsen CB, Overgaard UM, Mølle I, Severinsen MT, Strandholdt CN, Maibom J, Kodahl AR, Ryg J, Ravn P, Johansen IS, Helsø SN, Jensen‐fangel S, Kisielewicz J, Wiese L, Helleberg M, Kirk O, Clausen MR, Frederiksen H. SARS‐CoV‐2 infection among patients with haematological disorders: Severity and one‐month outcome in 66 Danish patients in a nationwide cohort study. Eur J Haematol 2021;106:72-81. [DOI: 10.1111/ejh.13519] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 229 |
Brar G, Pinheiro LC, Shusterman M, Swed B, Reshetnyak E, Soroka O, Chen F, Yamshon S, Vaughn J, Martin P, Paul D, Hidalgo M, Shah MA. COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study. J Clin Oncol 2020;38:3914-24. [PMID: 32986528 DOI: 10.1200/JCO.20.01580] [Cited by in Crossref: 79] [Cited by in F6Publishing: 84] [Article Influence: 26.3] [Reference Citation Analysis]
|
| 230 |
Tsatsakis A, Calina D, Falzone L, Petrakis D, Mitrut R, Siokas V, Pennisi M, Lanza G, Libra M, Doukas SG, Doukas PG, Kavali L, Bukhari A, Gadiparthi C, Vageli DP, Kofteridis DP, Spandidos DA, Paoliello MMB, Aschner M, Docea AO. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19. Food Chem Toxicol 2020;146:111769. [PMID: 32979398 DOI: 10.1016/j.fct.2020.111769] [Reference Citation Analysis]
|
| 231 |
Los-Arcos I, Iacoboni G, Aguilar-Guisado M, Alsina-Manrique L, Díaz de Heredia C, Fortuny-Guasch C, García-Cadenas I, García-Vidal C, González-Vicent M, Hernani R, Kwon M, Machado M, Martínez-Gómez X, Maldonado VO, Pla CP, Piñana JL, Pomar V, Reguera-Ortega JL, Salavert M, Soler-Palacín P, Vázquez-López L, Barba P, Ruiz-Camps I. Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper. Infection 2021;49:215-31. [PMID: 32979154 DOI: 10.1007/s15010-020-01521-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 232 |
Alzahrani M, Al-Mansour MM, Apostolidis J, Barefah A, Dada R, Alhejazi A, Alayed Y, Motabi I, Radwi M, Al-Hashmi H. Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic. Saudi J Med Med Sci 2020;8:227-38. [PMID: 32952517 DOI: 10.4103/sjmms.sjmms_457_20] [Reference Citation Analysis]
|
| 233 |
Raja M, Natori Y, Chandorkar A, Camargo JF, Simkins J, Andrews D, Bradley T, Watts J, Komanduri K, Morris MI, Fishman JE. Discordance Between Radiologic Findings and Molecular Testing in Patients With Underlying Hematologic Malignancy and Coronavirus Disease 2019. Open Forum Infect Dis 2020;7:ofaa372. [PMID: 32995351 DOI: 10.1093/ofid/ofaa372] [Reference Citation Analysis]
|
| 234 |
Giesen N, Sprute R, Rüthrich M, Khodamoradi Y, Mellinghoff SC, Beutel G, Lueck C, Koldehoff M, Hentrich M, Sandherr M, von Bergwelt-Baildon M, Wolf HH, Hirsch HH, Wörmann B, Cornely OA, Köhler P, Schalk E, von Lilienfeld-Toal M. Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). Eur J Cancer 2020;140:86-104. [PMID: 33068941 DOI: 10.1016/j.ejca.2020.09.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 235 |
Jani BD, Ho FK, Lowe DJ, Macbride-stewart S, Mair FS, Pell JP. Comparison of COVID-19 outcomes among shielded and non-shielded populations: A general population cohort study of 1.3 million.. [DOI: 10.1101/2020.09.17.20196436] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 236 |
Kothari D, Lee WD, Kim SK. Allium Flavonols: Health Benefits, Molecular Targets, and Bioavailability. Antioxidants (Basel) 2020;9:E888. [PMID: 32961762 DOI: 10.3390/antiox9090888] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 237 |
Kurniawan A, Halim DA, Sutandyo N. Multiple Myeloma Management in COVID-19 Era. Asian Journal of Oncology 2021;7:01-7. [DOI: 10.1055/s-0040-1716813] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 238 |
Liu C, Li L, Song K, Zhan ZY, Yao Y, Gong H, Chen Y, Wang Q, Dong X, Xie Z, Ou CQ, Hu Q, Song Q. A nomogram for predicting mortality in patients with COVID-19 and solid tumors: a multicenter retrospective cohort study. J Immunother Cancer 2020;8:e001314. [PMID: 32895296 DOI: 10.1136/jitc-2020-001314] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 239 |
Girmenia C, Gentile G, Micozzi A, Petrucci L, Malaspina F, Di Prima A, Baldacci E, Bianchi S, Pugliese P, Turriziani O, Antonelli G, Tombolini V, Foà R, Martelli M. COVID-19 in Patients with Hematologic Disorders Undergoing Therapy: Perspective of a Large Referral Hematology Center in Rome. Acta Haematol 2020;143:574-82. [PMID: 32932252 DOI: 10.1159/000510769] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 240 |
Mehta A, Vasudevan S, Parkash A, Sharma A, Vashist T, Krishna V. COVID-19 Mortality in Cancer Patients: A Report from a Tertiary Cancer Centre in India.. [DOI: 10.1101/2020.09.14.20194092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 241 |
Mato AR, Roeker LE, Lamanna N, Allan JN, Leslie L, Pagel JM, Patel K, Osterborg A, Wojenski D, Kamdar M, Huntington SF, Davids MS, Brown JR, Antic D, Jacobs R, Ahn IE, Pu J, Isaac KM, Barr PM, Ujjani CS, Geyer MB, Berman E, Zelenetz AD, Malakhov N, Furman RR, Koropsak M, Bailey N, Hanson L, Perini GF, Ma S, Ryan CE, Wiestner A, Portell CA, Shadman M, Chong EA, Brander DM, Sundaram S, Seddon AN, Seymour E, Patel M, Martinez-Calle N, Munir T, Walewska R, Broom A, Walter H, El-Sharkawi D, Parry H, Wilson MR, Patten PEM, Hernández-Rivas JÁ, Miras F, Fernández Escalada N, Ghione P, Nabhan C, Lebowitz S, Bhavsar E, López-Jiménez J, Naya D, Garcia-Marco JA, Skånland SS, Cordoba R, Eyre TA. Outcomes of COVID-19 in patients with CLL: a multicenter international experience. Blood 2020;136:1134-43. [PMID: 32688395 DOI: 10.1182/blood.2020006965] [Cited by in Crossref: 153] [Cited by in F6Publishing: 167] [Article Influence: 51.0] [Reference Citation Analysis]
|
| 242 |
Taniguchi S. 11) From the Perspective of Hematology. J Jpn Soc Intern Med 2020;109:2046-2048. [DOI: 10.2169/naika.109.2046] [Reference Citation Analysis]
|
| 243 |
Cattaneo C, Daffini R, Pagani C, Salvetti M, Mancini V, Borlenghi E, D'Adda M, Oberti M, Paini A, De Ciuceis C, Barbullushi K, Cancelli V, Belotti A, Re A, Motta M, Peli A, Bianchetti N, Anastasia A, Dalceggio D, Roccaro AM, Tucci A, Cairoli R, Muiesan ML, Rossi G. Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19. Cancer 2020;126:5069-76. [PMID: 32910456 DOI: 10.1002/cncr.33160] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 16.3] [Reference Citation Analysis]
|
| 244 |
Dandachi D, Geiger G, Montgomery MW, Karmen-Tuohy S, Golzy M, Antar AAR, Llibre JM, Camazine M, Díaz-De Santiago A, Carlucci PM, Zacharioudakis IM, Rahimian J, Wanjalla CN, Slim J, Arinze F, Kratz AMP, Jones JL, Patel SM, Kitchell E, Francis A, Ray M, Koren DE, Baddley JW, Hill B, Sax PE, Chow J; HIV-COVID-19 consortium. Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients with HIV and Coronavirus Disease-19. Clin Infect Dis 2020:ciaa1339. [PMID: 32905581 DOI: 10.1093/cid/ciaa1339] [Cited by in Crossref: 69] [Cited by in F6Publishing: 84] [Article Influence: 23.0] [Reference Citation Analysis]
|
| 245 |
Saini KS, Tagliamento M, Lambertini M, McNally R, Romano M, Leone M, Curigliano G, de Azambuja E. Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies. Eur J Cancer 2020;139:43-50. [PMID: 32971510 DOI: 10.1016/j.ejca.2020.08.011] [Cited by in Crossref: 190] [Cited by in F6Publishing: 155] [Article Influence: 63.3] [Reference Citation Analysis]
|
| 246 |
Kos I, Balensiefer B, Roth S, Ahlgrimm M, Sester M, Schmidt T, Thurner L, Bewarder M, Bals R, Lammert F, Stilgenbauer S, Kaddu-Mulindwa D. Prolonged Course of COVID-19-Associated Pneumonia in a B-Cell Depleted Patient After Rituximab. Front Oncol. 2020;10:1578. [PMID: 32984017 DOI: 10.3389/fonc.2020.01578] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 247 |
van Dam PA, Huizing M, Mestach G, Dierckxsens S, Tjalma W, Trinh XB, Papadimitriou K, Altintas S, Vermorken J, Vulsteke C, Janssens A, Berneman Z, Prenen H, Meuris L, Vanden Berghe W, Smits E, Peeters M. SARS-CoV-2 and cancer: Are they really partners in crime? Cancer Treat Rev 2020;89:102068. [PMID: 32731090 DOI: 10.1016/j.ctrv.2020.102068] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 18.3] [Reference Citation Analysis]
|
| 248 |
Haroon A, Alnassani M, Aljurf M, Ahmed SO, Shaheen M, Hanbli A, Chaudhari N, El Fakih R. COVID - 19 post Hematopoietic Cell Transplant, a Report of 11 Cases from a Single Center. Mediterr J Hematol Infect Dis. 2020;12:e2020070. [PMID: 32952981 DOI: 10.4084/mjhid.2020.070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 249 |
Cabero-Martínez A, Sánchez-Guijo F, López-Corral L, Pérez E, Avendaño A, Baile M, Cabrero M, Martín AA, Rodríguez A, Pérez B, Peña-Muñoz F, Román LG, Palomino D, López-Vázquez L, Vidriales MB, González-Diaz M, Mateos MV, Caballero MD. Measures to Maintain a SARS-CoV-2 Negative Inpatient Hematological Unit in the Midst of the COVID-19 Pandemic. Front Med (Lausanne) 2020;7:462. [PMID: 32984363 DOI: 10.3389/fmed.2020.00462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 250 |
Singh SRK, Thanikachalam K, Jabbour-Aida H, Poisson LM, Khan G. COVID-19 and Cancer: Lessons Learnt from a Michigan Hotspot. Cancers (Basel) 2020;12:E2377. [PMID: 32842584 DOI: 10.3390/cancers12092377] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 251 |
Wörmann B, Rüthrich MM, Einsele H, Tamm I, de Wit M, Trümper L, von Lilienfeld-toal M. COVID-19 und Onkologie: Anpassungsfähiges System. Deutsches Ärzteblatt Online 2020. [DOI: 10.3238/personko.2020.08.17.07] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 252 |
Isidori A, de Leval L, Gergis U, Musto P, Porcu P. Management of Patients With Hematologic Malignancies During the COVID-19 Pandemic: Practical Considerations and Lessons to Be Learned. Front Oncol 2020;10:1439. [PMID: 32923397 DOI: 10.3389/fonc.2020.01439] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 253 |
Varma A, Kosuri S, Ustun C, Ibrahim U, Moreira J, Bishop MR, Nathan S, Mehta J, Moncayo D, Heng J, Osman K, Adekola KUA. COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter. Leukemia. 2020;34:2809-2812. [PMID: 32801310 DOI: 10.1038/s41375-020-01019-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 254 |
Rubinstein SM, Warner JL. COVID-19 and haematological malignancy: navigating a narrow strait. Lancet Haematol 2020;7:e701-3. [PMID: 32798474 DOI: 10.1016/S2352-3026(20)30252-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 255 |
Passamonti F, Cattaneo C, Arcaini L, Bruna R, Cavo M, Merli F, Angelucci E, Krampera M, Cairoli R, Della Porta MG, Fracchiolla N, Ladetto M, Gambacorti Passerini C, Salvini M, Marchetti M, Lemoli R, Molteni A, Busca A, Cuneo A, Romano A, Giuliani N, Galimberti S, Corso A, Morotti A, Falini B, Billio A, Gherlinzoni F, Visani G, Tisi MC, Tafuri A, Tosi P, Lanza F, Massaia M, Turrini M, Ferrara F, Gurrieri C, Vallisa D, Martelli M, Derenzini E, Guarini A, Conconi A, Cuccaro A, Cudillo L, Russo D, Ciambelli F, Scattolin AM, Luppi M, Selleri C, Ortu La Barbera E, Ferrandina C, Di Renzo N, Olivieri A, Bocchia M, Gentile M, Marchesi F, Musto P, Federici AB, Candoni A, Venditti A, Fava C, Pinto A, Galieni P, Rigacci L, Armiento D, Pane F, Oberti M, Zappasodi P, Visco C, Franchi M, Grossi PA, Bertù L, Corrao G, Pagano L, Corradini P; ITA-HEMA-COV Investigators. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol 2020;7:e737-45. [PMID: 32798473 DOI: 10.1016/S2352-3026(20)30251-9] [Cited by in Crossref: 272] [Cited by in F6Publishing: 293] [Article Influence: 90.7] [Reference Citation Analysis]
|
| 256 |
Fox TA, Troy-Barnes E, Kirkwood AA, Chan WY, Day JW, Chavda SJ, Kumar EA, David K, Tomkins O, Sanchez E, Scully M, Khwaja A, Lambert J, Singer M, Roddie C, Morris EC, Yong KL, Thomson KJ, Ardeshna KM. Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapy. Br J Haematol. 2020;191:194-206. [PMID: 32678948 DOI: 10.1111/bjh.17027] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 12.7] [Reference Citation Analysis]
|
| 257 |
Sanchez-Pina JM, Rodríguez Rodriguez M, Castro Quismondo N, Gil Manso R, Colmenares R, Gil Alos D, Paciello ML, Zafra D, Garcia-Sanchez C, Villegas C, Cuellar C, Carreño-Tarragona G, Zamanillo I, Poza M, Iñiguez R, Gutierrez X, Alonso R, Rodríguez A, Folgueira MD, Delgado R, Ferrari JM, Lizasoain M, Aguado JM, Ayala R, Martinez-Lopez J, Calbacho M. Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies. Eur J Haematol 2020;105:597-607. [PMID: 32710500 DOI: 10.1111/ejh.13493] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 17.0] [Reference Citation Analysis]
|
| 258 |
Shah V, Ko Ko T, Zuckerman M, Vidler J, Sharif S, Mehra V, Gandhi S, Kuhnl A, Yallop D, Avenoso D, Rice C, Sanderson R, Sarma A, Marsh J, de Lavallade H, Krishnamurthy P, Patten P, Benjamin R, Potter V, Ceesay MM, Mufti GJ, Norton S, Pagliuca A, Galloway J, Kulasekararaj AG. Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience. Br J Haematol 2020;190:e279-82. [PMID: 32526039 DOI: 10.1111/bjh.16935] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 21.0] [Reference Citation Analysis]
|
| 259 |
Khan AM, Ajmal Z, Raval M, Tobin E. Concurrent Diagnosis of Acute Myeloid Leukemia and COVID-19: A Management Challenge. Cureus 2020;12:e9629. [PMID: 32923230 DOI: 10.7759/cureus.9629] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 260 |
Infante MS, González-Gascón Y Marín I, Muñoz-Novas C, Churruca J, Foncillas MÁ, Landete E, Marín K, Ryan P, Hernández-Rivas JÁ. COVID-19 in patients with hematological malignancies: A retrospective case series. Int J Lab Hematol 2020;42:e256-9. [PMID: 32749757 DOI: 10.1111/ijlh.13301] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 261 |
Piciocchi A, Messina M, Soddu S, La Sala E, Paoloni F, Giuliani G, Marino MR, Petrelli C, Gorreo Renzulli L, Fazi P, Vignetti M. The COVID-19 pandemic and management of GIMEMA clinical trials: changes and challenges. Br J Haematol 2020;190:e211-4. [PMID: 32621754 DOI: 10.1111/bjh.16996] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 262 |
Bao R, Hernandez K, Huang L, Luke JJ. ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19. J Immunother Cancer. 2020;8. [PMID: 32675312 DOI: 10.1136/jitc-2020-001020] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 263 |
ElGohary GM, Hashmi S, Styczynski J, Kharfan-Dabaja MA, Alblooshi RM, de la Cámara R, Mohmed S, Alshaibani A, Cesaro S, Abd El-Aziz N, Almaghrabi R, Gergis U, Majhail NS, El-Gohary Y, Chemaly RF, Aljurf M, El Fakih R. The risk and prognosis of COVID-19 infection in cancer patients: A systematic review and meta-analysis. Hematol Oncol Stem Cell Ther 2020:S1658-3876(20)30122-9. [PMID: 32745466 DOI: 10.1016/j.hemonc.2020.07.005] [Cited by in Crossref: 56] [Cited by in F6Publishing: 71] [Article Influence: 18.7] [Reference Citation Analysis]
|
| 264 |
Hultcrantz M, Richter J, Rosenbaum CA, Patel D, Smith EL, Korde N, Lu SX, Mailankody S, Shah UA, Lesokhin AM, Hassoun H, Tan C, Maura F, Derkach A, Diamond B, Rossi A, Pearse RN, Madduri D, Chari A, Kaminetzky D, Braunstein MJ, Gordillo C, Reshef R, Taur Y, Davies FE, Jagannath S, Niesvizky R, Lentzsch S, Morgan GJ, Landgren O. COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers. Blood Cancer Discov 2020;1:234-43. [DOI: 10.1158/2643-3230.bcd-20-0102] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 265 |
Rossi D, Shadman M, Condoluci A, Brown JR, Byrd JC, Gaidano G, Hallek M, Hillmen P, Mato A, Montserrat E, Ghia P. How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic. Hemasphere 2020;4:e432. [PMID: 32803132 DOI: 10.1097/HS9.0000000000000432] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 266 |
Cheung CKM, Law MF, Lui GCY, Wong SH, Wong RSM. Coronavirus Disease 2019 (COVID-19): A Haematologist's Perspective. Acta Haematol 2021;144:10-23. [PMID: 32721958 DOI: 10.1159/000510178] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 267 |
Sica A, Colombo MP, Trama A, Horn L, Garassino MC, Torri V. Immunometabolic Status of COVID-19 Cancer Patients. Physiol Rev 2020;100:1839-50. [PMID: 32721181 DOI: 10.1152/physrev.00018.2020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 268 |
Shi L, Wang Y, Liang X, Xiao W, Duan G, Yang H, Wang Y. Is neutrophilia associated with mortality in COVID-19 patients? A meta-analysis and meta-regression. Int J Lab Hematol 2020;42:e244-7. [PMID: 32779881 DOI: 10.1111/ijlh.13298] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 269 |
Li Q, Chen L, Li Q, He W, Yu J, Chen L, Cao Y, Chen W, Di Wu, Dong F, Cai L, Ran Q, Li L, Liu Q, Ren W, Gao F, Wang H, Chen Z, Gale RP, Hu Y. Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission. Leukemia 2020;34:2384-91. [PMID: 32690880 DOI: 10.1038/s41375-020-0986-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 270 |
Wilson AJ, Troy-Barnes E, Subhan M, Clark F, Gupta R, Fielding AK, Kottaridis P, Mansour MR, O'Nions J, Payne E, Chavda N, Baker R, Thomson K, Khwaja A. Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19. Br J Haematol 2020;190:e189-91. [PMID: 32584418 DOI: 10.1111/bjh.16962] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 271 |
Zhou X, Bai T, Meckel K, Song J, Jin Y, Kortüm KM, Einsele H, Hou X, Rasche L. COVID-19 infection in patients with multiple myeloma: a German-Chinese experience from Würzburg and Wuhan. Ann Hematol 2021;100:843-6. [PMID: 32683456 DOI: 10.1007/s00277-020-04184-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 272 |
Monreal E, de la Maza SS, Natera-villalba E, Beltrán-corbellini Á, Rodríguez-jorge F, Fernández-velasco JI, Walo-delgado P, Muriel A, Zamora J, Alonso-canovas A, Fortún J, Manzano L, Montero-errasquín B, Costa-frossard L, Masjuan J, María Villar L, for the COVID-HRC group. HIGH VERSUS STANDARD DOSES OF CORTICOSTEROIDS IN COVID-19 PATIENTS WITH AN ACUTE RESPIRATORY DISTRESS SYNDROME: a controlled observational comparative study.. [DOI: 10.1101/2020.07.17.20156315] [Reference Citation Analysis]
|
| 273 |
El-Sharkawi D, Iyengar S. Haematological cancers and the risk of severe COVID-19: Exploration and critical evaluation of the evidence to date. Br J Haematol 2020;190:336-45. [PMID: 32559308 DOI: 10.1111/bjh.16956] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 274 |
Booth S, Willan J, Wong H, Khan D, Farnell R, Hunter A, Eyre T, Katz H, Dungarwalla M, Chen L, Browning J, Polzella P, Gray N, Neelakantan P, Dhillon EK, Dutton D, Sternberg A, Prideaux S, Collins GP, Peniket A. Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy. Eur J Haematol 2020;105:476-83. [PMID: 32544294 DOI: 10.1111/ejh.13469] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 275 |
Sahu KK, Cerny J. Managing patients with hematological malignancies during COVID-19 pandemic. Expert Review of Hematology 2020;13:787-93. [DOI: 10.1080/17474086.2020.1787147] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 276 |
Romito F, Dellino M, Loseto G, Opinto G, Silvestris E, Cormio C, Guarini A, Minoia C. Psychological Distress in Outpatients With Lymphoma During the COVID-19 Pandemic. Front Oncol 2020;10:1270. [PMID: 32754447 DOI: 10.3389/fonc.2020.01270] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 21.3] [Reference Citation Analysis]
|
| 277 |
van Doesum J, Chinea A, Pagliaro M, Pasquini MC, van Meerten T, Bakker M, Ammatuna E. Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands. Leukemia 2020;34:2536-8. [PMID: 32641731 DOI: 10.1038/s41375-020-0960-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 278 |
Langabeer SE. Reduction in molecular diagnostics of myeloproliferative neoplasms during the COVID-19 pandemic. Ir J Med Sci 2021;190:27-8. [PMID: 32638153 DOI: 10.1007/s11845-020-02303-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 279 |
Lattenist R, Yildiz H, De Greef J, Bailly S, Yombi JC. COVID-19 in Adult Patients with Hematological Disease: Analysis of Clinical Characteristics and Outcomes. Indian J Hematol Blood Transfus. 2020;1-5. [PMID: 32837052 DOI: 10.1007/s12288-020-01318-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 280 |
Boyd K, Parcell B, Tauro S. Immunosuppression in hematological cancer patients with Covid-19 -Uncomplicated infections but delayed viral clearance? Leuk Res 2020;96:106407. [PMID: 32652329 DOI: 10.1016/j.leukres.2020.106407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 281 |
Fürstenau M, Langerbeins P, De Silva N, Fink AM, Robrecht S, von Tresckow J, Simon F, Hohloch K, Droogendijk J, van der Klift M, van der Spek E, Illmer T, Schöttker B, Fischer K, Wendtner CM, Tausch E, Stilgenbauer S, Niemann CU, Gregor M, Kater AP, Hallek M, Eichhorst B. COVID-19 among fit patients with CLL treated with venetoclax-based combinations. Leukemia 2020;34:2225-9. [PMID: 32601378 DOI: 10.1038/s41375-020-0941-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 282 |
Kanellopoulos A, Ahmed MZ, Kishore B, Lovell R, Horgan C, Paneesha S, Lloyd R, Salhan B, Giles H, Chauhan S, Venkatadasari I, Khakwani M, Murthy V, Xenou E, Dassanayake H, Srinath S, Kaparou M, Nikolousis E. COVID-19 in bone marrow transplant recipients: reflecting on a single centre experience. Br J Haematol 2020;190:e67-70. [PMID: 32469077 DOI: 10.1111/bjh.16856] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 283 |
Ferrara F, Zappasodi P, Roncoroni E, Borlenghi E, Rossi G. Impact of Covid-19 on the treatment of acute myeloid leukemia. Leukemia 2020;34:2254-6. [PMID: 32561842 DOI: 10.1038/s41375-020-0925-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 284 |
Zeidan AM, Boddu PC, Patnaik MM, Bewersdorf JP, Stahl M, Rampal RK, Shallis R, Steensma DP, Savona MR, Sekeres MA, Roboz GJ, DeAngelo DJ, Schuh AC, Padron E, Zeidner JF, Walter RB, Onida F, Fathi A, DeZern A, Hobbs G, Stein EM, Vyas P, Wei AH, Bowen DT, Montesinos P, Griffiths EA, Verma AK, Keyzner A, Bar-Natan M, Navada SC, Kremyanskaya M, Goldberg AD, Al-Kali A, Heaney ML, Nazha A, Salman H, Luger S, Pratz KW, Konig H, Komrokji R, Deininger M, Cirici BX, Bhatt VR, Silverman LR, Erba HP, Fenaux P, Platzbecker U, Santini V, Wang ES, Tallman MS, Stone RM, Mascarenhas J. Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts. Lancet Haematol 2020;7:e601-12. [PMID: 32563283 DOI: 10.1016/S2352-3026(20)30205-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 13.7] [Reference Citation Analysis]
|
| 285 |
Allegra A, Pioggia G, Tonacci A, Musolino C, Gangemi S. Cancer and SARS-CoV-2 Infection: Diagnostic and Therapeutic Challenges. Cancers (Basel) 2020;12:E1581. [PMID: 32549297 DOI: 10.3390/cancers12061581] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 286 |
Gale RP. Can a disease be conquered by extensive publications, reading guidelines and interminable meetings? Leukemia 2020;34:1977-8. [PMID: 32528041 DOI: 10.1038/s41375-020-0897-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 287 |
Hatzl S, Eisner F, Schilcher G, Kreuzer P, Gornicec M, Eller P, Brodmann M, Schlenke P, Stradner MH, Krause R, Greinix H, Schulz E. Response to "COVID-19 in persons with haematological cancers". Leukemia 2020;34:2265-70. [PMID: 32528043 DOI: 10.1038/s41375-020-0914-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 288 |
Li Q, Cao Y, Chen L, Wu D, Yu J, Wang H, He W, Chen L, Dong F, Chen W, Chen W, Li L, Ran Q, Liu Q, Ren W, Gao F, Chen Z, Gale RP, Hu Y. Hematological features of persons with COVID-19. Leukemia 2020;34:2163-72. [PMID: 32528042 DOI: 10.1038/s41375-020-0910-1] [Cited by in Crossref: 66] [Cited by in F6Publishing: 74] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 289 |
Alves Barbosa O, Guimarães Andrade T, de Almeida Sousa MD, Correia JW. COVID-19 in a Patient with Chronic Lymphocytic Leukaemia with Pseudohypoxemia. Eur J Case Rep Intern Med 2020;7:001763. [PMID: 32665936 DOI: 10.12890/2020_001763] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 290 |
Abid MA, Nunley L, Abid MB. Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline. Front Immunol 2020;11:1294. [PMID: 32582221 DOI: 10.3389/fimmu.2020.01294] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 291 |
Palmieri C, Palmer D, Openshaw PJM, Baillie JK, Semple MG, Turtle L. Cancer datasets and the SARS-CoV-2 pandemic: establishing principles for collaboration. ESMO Open 2020;5:e000825. [PMID: 32457054 DOI: 10.1136/esmoopen-2020-000825] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 292 |
Dhakal B, D'Souza A, Chhabra S, Hari P. Multiple myeloma and COVID-19. Leukemia 2020;34:1961-3. [PMID: 32475990 DOI: 10.1038/s41375-020-0879-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 293 |
Link H. Müssen wir die Supportivtherapie bei Krebspatienten anpassen? Im Fokus Onkologie 2020;23:40-44. [DOI: 10.1007/s15015-020-2437-8] [Reference Citation Analysis]
|
| 294 |
Martín-Moro F, Marquet J, Piris M, Michael BM, Sáez AJ, Corona M, Jiménez C, Astibia B, García I, Rodríguez E, García-Hoz C, Fortún-Abete J, Herrera P, López-Jiménez J. Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies. Br J Haematol 2020;190:e16-20. [PMID: 32379921 DOI: 10.1111/bjh.16801] [Cited by in Crossref: 106] [Cited by in F6Publishing: 111] [Article Influence: 35.3] [Reference Citation Analysis]
|
| 295 |
Fattizzo B, Giannotta JA, Sciumè M, Cattaneo D, Bucelli C, Fracchiolla NS, Onida F, Baldini L, Barcellini W, Iurlo A. Reply to "COVID-19 in persons with haematological cancers": a focus on myeloid neoplasms and risk factors for mortality. Leukemia 2020;34:1957-60. [PMID: 32457356 DOI: 10.1038/s41375-020-0877-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 296 |
Wang Y, Shi L, Yang H, Duan G, Wang Y. Acute kidney injury is associated with the mortality of coronavirus disease 2019. J Med Virol 2020;92:2335-7. [PMID: 32410212 DOI: 10.1002/jmv.26019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 297 |
Gale RP. Perspective: Cell therapy, SARS-CoV-2, COVID-19, and James Lind. Adv Cell Gene Ther 2020;:e88. [PMID: 32838211 DOI: 10.1002/acg2.88] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 298 |
Li W, Wang D, Guo J, Yuan G, Yang Z, Gale RP, You Y, Chen Z, Chen S, Wan C, Zhu X, Chang W, Sheng L, Cheng H, Zhang Y, Li Q, Qin J, Meng L, Jiang Q; Hubei Anti-Cancer Association. COVID-19 in persons with chronic myeloid leukaemia. Leukemia 2020;34:1799-804. [PMID: 32424293 DOI: 10.1038/s41375-020-0853-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 16.3] [Reference Citation Analysis]
|
| 299 |
Gale RP. Treating Plasma Cell Myeloma in Developing Countries: Does Everyone Need the Newest Drugs? Acta Haematol 2020;143:513-5. [PMID: 32155631 DOI: 10.1159/000505991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 300 |
Bagal B, Munot P, Nayak L. COVID-19 in hematological malignancies. Cancer Res Stat Treat 2020;3:345. [DOI: 10.4103/crst.crst_182_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
